Stockwinners Market Radar for May 09, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:32 EDT Eisai, Biogen complete rolling FDA submission for Lecanemab biologics license - Eisai (ESALY) and Biogen (BIIB) announced that Eisai has completed the rolling submission to the U.S. Food and Drug Administration of a Biologics License Application under the accelerated approval pathway for the investigational anti-amyloid beta protofibril antibody lecanemab for the treatment of mild cognitive impairment due to Alzheimer's disease and mild AD with confirmed presence of amyloid pathology in the brain. As part of the completed rolling submission, Eisai has requested Priority Review. If the FDA accepts the BLA, the Prescription Drug User Fee Act action date will be set. While Eisai is currently submitting lecanemab under the accelerated approval pathway, the lecanemab Phase 3 confirmatory Clarity AD clinical trial conducted with 1,795 patients will report out in the Fall of 2022. The FDA has agreed that the results of Clarity AD, when completed, can serve as the confirmatory study to verify the clinical benefit of lecanemab. Dependent upon the results of the Clarity AD clinical trial, Eisai may submit for full approval of lecanemab to the FDA during fiscal year 2022.

18:34 EDT Papa John's CEO: Our business is hitting on all cylinders - In an interview on CNBC's Mad Money, Rob Lynch said this operating environment is a challenge from all standpoints, but the team is delivering. "We have not seen this level of food inflation in 40 years." The staffing situation has gotten "progressively better," he noted. Demand is still huge and servicing orders has been a challenge. He sees light at the end of the tunnel from a commodity standpoint. Papa John's has been in China for some time, but it's very underdeveloped relative to peers, he added. He feels the country represents a huge opportunity.

18:00 EDT Upstart drops 44% to $43.30 after cutting FY22 guidance

17:47 EDT Nicolet Bankshares to transfer its common stock from NASDAQ to the NYSE - Nicolet Bankshares announced that it is transferring the listing of its common stock to the NYSE from The Nasdaq Stock Market. The Company's common stock is expected to begin trading on the NYSE on May 24 under the ticker symbol of "NIC". Nicolet will continue to trade its common stock on Nasdaq until the close of the market on May 23.

17:35 EDT Ovintiv increases quarterly dividend 25% - Ovintiv's board declared a quarterly dividend of 25c per share of common stock payable on June 30 to shareholders of record as of June 15. This represents an increase of 25% to the dividend paid in Q1 and marks the third dividend increase in the last year.

17:31 EDT Enerpac Tool appoints Anthony Colucci as EVP and CFO - Enerpac Tool Group announced that Anthony "Tony" Colucci will join the Company as EVP and CFO effective May 30. He will report to Paul Sternlieb, President & CEO, of Enerpac Tool Group, and serve as a member of the Company's executive leadership team. Mr. Colucci will provide leadership over all aspects of the Company's finance and IT functions globally. Colucci joins Enerpac Tool Group from Robertshaw Industries, a global industrial manufacturer and engineering company providing components and systems solutions into the residential white goods, commercial appliance, HVAC, and transportation industries. Most recently, he held the position of EVP & Chief Finance and Administrative Officer. He brings a strong focus on partnering with commercial and operations teams to accelerate topline growth, improve financial processes, and drive efficiency, productivity, and cost reduction.

17:18 EDT Highwoods Properties acquires two properties in Charlotte - Highwoods Properties announced two planned acquisitions in the Charlotte market. First, the company has agreed to acquire 650 South Tryon at Legacy Union in Charlotte's Uptown CBD submarket for a total expected investment of $203M, including $3.9M of anticipated leasing capital expenditures to bring the property to stabilization. The acquisition of 650 South Tryon, which is subject to customary closing conditions, is scheduled to close in Q3. Second, the company has agreed to acquire a mixed-use development site located at 1426 South Tryon Street in the heart of Charlotte's dynamic South End submarket for $27M. The acquisition of 1426 South Tryon, which is also subject to customary closing conditions, is scheduled to close in Q2.

17:03 EDT Aris Water Solutions sees FY22 adjusted EBITDA $165M-$175M - Aris is updating its 2022 outlook to reflect the impact of the recently signed long-term agreement with Chevron as well as increased activity levels in the Northern Delaware Basin. For the year of 2022, Aris is now projecting increased Adjusted EBITDA between $165.0 and $175.0 million and property, plant, and equipment expenditures between $140.0 and $150.0 million. For the second quarter of 2022, Aris projects Adjusted EBITDA of $38.0-$40.0 million. Aris is investing additional capital in 2022 to support the Chevron agreement as well as incremental projected growth from our other long-term contracted customers.

17:00 EDT Citi in talks with 'number of potential buyers' for Russia operations - Citi said in a regulatory filing that it expanded the scope in Q1 of the divestiture of certain activities in Russia beyond the consumer business to include commercial banking. Citi has commenced sale discussions with a number of potential buyers. Any additional financial or economic sanctions that may be implemented by the U.S., the U.K., the EU and any other jurisdictions, as well as any governmental approvals that may be required for any transaction, may cause delays or reduce the certainty of such transaction being concluded. Such delays may be significant. Citi's continued operations in Russia subject it to various risks, including, among others, foreign currency volatility, including devaluations; business restrictions; sanctions or asset freezes; or other deconsolidation events. Examples of triggers that may result in deconsolidation of AO Citibank include voluntary or forced sale of ownership or loss of control due to actions of relevant governmental authorities, including expropriation; revocation of banking license; and loss of ability to elect a board of directors or appoint members of senior management. As of March 31, 2022, Citi continued to consolidate AO Citibank because none of the deconsolidation triggers was met. In the event of a loss of control or substantial liquidation of AO Citibank, Citi would be required to write off its net investment of approximately $0.7B recognize a CTA loss of approximately $1B through earnings. Once recognized in earnings, this CTA loss would be removed from the AOCI component of equity and therefore would have a neutral impact to Citi's Capital. As discussed above, the majority of Citi's net investment was hedged for foreign currency depreciation as of March 31, 2022.

16:51 EDT Caribou Biosciences announces upcoming milestones - Anticipated Milestones for 2022 and Beyond: CB-010: Caribou is scheduled to share initial data from its ongoing ANTLER Phase 1 trial for CB-010, an anti-CD19 CAR-T cell therapy for r/r B- NHL, at EHA in June 2022. CB-011: Caribou expects to submit an IND application for CB-011, an anti-BCMA CAR-T cell therapy for r/r MM, in H2 2022. CB-020: Caribou expects to announce target selection for CB-020, an iPSC-derived CAR-NK cell therapy for solid tumors, in Q4 2022. Additionally, Caribou expects to disclose multiple armoring strategies under development for its CAR-NK platform in Q4 2022. CB-012: Caribou expects to submit an IND application for CB-012, an anti-CD371 CAR-T cell therapy for r/r AML, in 2023.

16:49 EDT Intevac sees FY22 hard drive revenue around $35M - Sees 66% of FY22 revenue being accrued in second half. Sees FY22 gross margins in high 30% range.

16:45 EDT Geron backs FY22 OpEx view $155M-$165M - For fiscal year 2022, under generally accepted accounting principles (GAAP), the Company continues to expect total operating expenses in the range of approximately $155 million to $165 million, which includes non-cash items such as: stock-based compensation expense, amortization of debt discounts and issuance costs and depreciation and amortization. The Company continues to expect non-GAAP total operating expenses for fiscal year 2022, which excludes estimated non-cash items such as: stock-based compensation expense, amortization of debt discounts and issuance costs and depreciation and amortization, in the range of approximately $140 million to $150 million.

16:45 EDT Bluebird Bio sees FY cash burn less than $340M - The full-year 2022 cash burn is expected to be less than $340 million with a 35 to 40 percent reduction in operating costs anticipated by year-end 2022.

16:39 EDT Invacare sees FY22 revenue flat or slightly lower vs. last year - As a result of the company participating in growing markets, strong product demand, continued elevated backlog, and with the consideration of the planned restructuring actions to improve profitability, the company reaffirms its financial guidance for the full year 2022, in which the company anticipates: Adjusted EBITDA, excluding the benefit of CARES Act loan forgiveness in 2021, and free cash flow to improve compared to the prior year; Sequential quarterly improvement for Adjusted EBITDA the balance of the year as the expected strategic actions take effect; and, Revenues to be flat or slightly lower compared to the prior year as the product portfolio is further optimized.

16:39 EDT Lemonade up 4% after Q1 reports - Lemonade shares are up 73c, or 4%, to $19.23 in after-hours trading.

16:36 EDT Neoleukin Therapeutics expects cash to fund operations through 2023 - Cash and cash equivalents totaled $128.1 million as of March 31, 2022, compared to $142.5 million as of December 31, 2021. Based upon current internal infrastructure and pipeline initiatives, Neoleukin believes it has sufficient cash to fund operations through 2023.

16:33 EDT Information Services board increases quarterly dividend 33% to 4c - The ISG Board of Directors approved a 33% increase in the quarterly dividend, from 3c per share to 4c per share, effective with the next quarterly dividend, payable on June 17, 2022, to shareholders of record on June 3, 2022.

16:32 EDT Curaleaf names Matt Darin as CEO, succeeding Joe Bayern - Curaleaf Holdings announced that Matt Darin will become CEO, effective May 9, while current CEO Joe Bayern will launch and run a new division of Curaleaf developing a new CPG-based business model. Darin will report to the board and will work closely with Bayern during the transition period through the second quarter.

16:30 EDT Vroom names Tom Shortt CEO - Vroom announced that its Board of Directors has appointed Tom Shortt, who previously served as the Company's Chief Operating Officer, as Chief Executive Officer and a member of Vroom's Board of Directors, effective immediately. He succeeds Paul Hennessy, who has stepped down to pursue other opportunities. Robert Mylod, the current Board Chair, will become Independent Executive Chair of the Board. Mylod said: "today's announcement is the culmination of a thoughtful succession planning process by the Board to ensure continuity of leadership while positioning Vroom for long-term success. I would like to thank Paul for his many years of service at Vroom. During his time as CEO, Paul oversaw Vroom's transition from a start-up to one of the largest auto retailers in the United States. While doing so, he recruited and cultivated an outstanding management team-including Tom Shortt-that is now ready to lead Vroom for years to come. I am grateful for his leadership and his friendship."

16:29 EDT Oric Pharmaceuticals expects cash to fund operations into second half of 2024 - Cash, cash equivalents and investments totaled $256.2 million as of March 31, 2022, which the company expects will fund its current operating plan into the second half of 2024.

16:28 EDT Pzena Investment reports preliminary AUM $49.5B at April 30 - Compared to $52.8B at March 31, and $50.3B at April 30, 2021.

16:27 EDT Plug Power reaffirming 2025 targets - Plug Power stated: "We are reaffirming our 2025 targets to achieve $3B in annual sales, 30% gross margin, and 17% operating margin. Revenue growth will be driven by the continuing development of both new and existing pedestal customers with significant portfolio sales opportunities. Our green hydrogen generation network will make green hydrogen ubiquitous and economical, helping drive demand and cost improvements for fuel cell applications across multiple industries... Equally important, Plug has put into place the drivers to achieve 30% gross margin and 17% operating margin by 2025."

16:26 EDT Otonomy announces upcoming milestones - Anticipated Upcoming Milestones: In August 2022, announce top-line results for OTO-313 Phase 2 clinical trial. In second half of 2022, announce safety results for OTO-313 bilateral and higher dosing. In second half of 2022, announce top-line results for OTO-413 higher dose evaluation. By end of 2022, initiate Phase 2 dose-ranging efficacy trial for OTO-413 in hearing loss. In first half of 2023, initiate Phase 3 clinical program for OTO-313 in tinnitus. In first half of 2023, file IND for OTO-825 in hearing loss associated with GJB2 gene mutation.

16:26 EDT Otonomy expects acsh to fund operations into second half of 2023 - Otonomy expects that its current cash, cash equivalents, and short-term investments will be sufficient to fund company operations into the second half of 2023.

16:25 EDT Helios Technologies to acquire Taimi, terms not disclosed - Helios Technologies has entered into a definitive agreement to acquire the assets of Taimi R&D. Founded in 2005, Taimi is a Canadian manufacturer of innovative hydraulic components that offer ball-less design swivel products which improve hydraulic reliability of equipment, increase the service life of components, and help protect the environment by reducing leakage. Josef Matosevic, Helios' President and Chief Executive Officer, commented, "Bolting Taimi onto our pure play Hydraulics platform is a clear demonstration of the continued progress we are making with our flywheel acquisition strategy. Taimi produces high quality, uniquely designed components that when integrated with our existing technologies form hydraulic solutions that offer higher reliability, greater durability, and safety and environmental benefits. We are excited to expand our Hydraulics solutions and enhance our technical expertise with Taimi's innovative team. Their team brings not only technology but also strong engineering expertise. Importantly, we continue to execute on our augmented strategy to drive value for our customers with our integrated innovation teams across Helios. We believe this approach helps us maintain a market leading position and ultimately delivers for all of our stakeholders." Helios expects to close the transaction in the third quarter of 2022 or as soon as practicable, subject to customary closing conditions. Terms of the acquisition were not disclosed.

16:24 EDT Cohen & Steers reports preliminary AUM $98B as of April 30 - A decrease of $4.1B from assets under management at March 31. The decrease was due to market depreciation of $3.9B and distributions of $188M, partially offset by net inflows of $3M.

16:23 EDT Longeveron CEO Geoff Green to resign - Longeveron announced the resignation of CEO Geoff Green, who is leaving the company effective June 1 to pursue new opportunities. Longeveron's board has approved the appointment of current Chief Medical Officer, K. Chris Min, M.D., Ph.D., as interim CEO, to succeed Green. The board has formed a search committee and retained an executive search firm to assist in identifying a permanent CEO. The company currently intends to enter into a consulting agreement with Green to further ensure a smooth transition.

16:21 EDT Hyatt unveils new Inclusive Collection luxury resort brands - Hyatt Hotels Corporation announced the Inclusive Collection, "a new global portfolio of nine distinct luxury all-inclusive resort brands. Resorts in Hyatt's Inclusive Collection deliver immersive, elevated and seamless all-inclusive experiences - helping guests and members celebrate the big moments, little moments, and everything in between."

16:19 EDT Microchip increased quarterly dividend 9.1% - Microchip Technology announced that its board declared a quarterly cash dividend on its common stock of 27.6c per share. The dividend is payable on June 3 to stockholders of record on May 20. "Microchip's financial performance in the March 2022 quarter was very strong, resulting in solid cash generation and significant debt reduction," said Steve Sanghi, Executive Chair. "Today, our Board of Directors approved a sequential increase in our dividend of 9.1% to 27.6 cents per share, up from our February dividend of 25.3 cents per share. Also, our Board is now targeting to increase our dividend at least 9% sequentially, which is up from the 7% sequential increases communicated at our Investor and Analyst Day on November 8, 2021. These actions reflect confidence in the cash-generating capability of our business, as well as our ongoing commitment to returning capital to our stockholders."

16:14 EDT PPG shareholders vote to eliminate supermajority voting requirements - PPG reconvened its adjourned annual meeting virtually where shareholders voted to amend the company's Articles of Incorporation and Bylaws to replace the supermajority voting requirements. The PPG Board of Directors had recommended that shareholders vote "FOR" the proposal, enhancing PPG's corporate governance practices. "We are proud that our shareholders have voted to replace the supermajority voting requirements, which will further modernize PPG's governance as part of our continued ESG focus," said PPG chairman and CEO Michael McGarry. "Obtaining the affirmative vote of 80% of our outstanding shares for this proposal required a significant shareholder outreach effort this year." Efforts by PPG included mailing paper copies of proxy materials to many shareholders, sending multiple reminder letters and emails and engaging a highly-regarded proxy solicitor who made over 60,000 phone calls encouraging shareholders to vote their shares. PPG's annual meeting commenced on April 21, 2022 and was adjourned solely to allow additional time for shareholders to vote on this proposal. On April 21, 2022, shareholders re-elected directors Gary R. Heminger, retired chairman and chief executive officer, Marathon Petroleum Corporation; Kathleen A. Ligocki, former chief executive officer of Agility Fuel Solutions, LLC; and Michael T. Nally, chief executive officer, Generate Biomedicines, Inc. and CEO-partner of Flagship Pioneering, in addition to McGarry. Shareholders also passed a non-binding resolution to approve the compensation of the company's named executive officers and ratified the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for 2022. Shareholders voted against a proposal to adopt a policy of setting target amounts of CEO compensation.

16:12 EDT Annexon expects cash to fund operations into 2024 - Cash and cash equivalents and short-term investments were $206.7M as of March 31, 2022. Annexon continues to expect that its current cash position is sufficient to fund its operating plans into 2024.

16:12 EDT XPO Logistics announces Drew Wilkerson as CEO for spin-off - XPO Logistics announced that Drew Wilkerson, currently XPO's president of North American Transportation, will become CEO of the company's planned spin-off of its tech-enabled brokered services platform. Wilkerson will transition to the CEO role with the spin-off, which the company expects to complete in Q4 of this year. As previously announced, XPO intends to spin off its tech-enabled brokered services platform from its less-than-truckload business, creating two separate, publicly traded companies at the top of their industries in North America. The core business of the spin-off will be XPO's best-in-class truck brokerage service, with complementary brokered services for last mile logistics, managed transportation and global forwarding. All four asset-light operations are in the North American Transportation division currently led by Wilkerson.

16:11 EDT Datto withdraws FY22 guidance - Given the pending acquisition by Kaseya, which is subject to regulatory approvals in addition to the satisfaction of customary closing conditions, Datto is withdrawing its prior guidance for full year 2022 and will not be providing guidance going forward.

16:10 EDT Synchronoss to provide wholesale process automation to Brightspeed - Synchronoss Technologies (SNCR) announced that it has signed a multi-year agreement with Brightspeed, a provider of broadband and telecommunications services expected to have operations in 20 States. Brightspeed will initially be comprised of the incumbent local exchange carrier assets and associated operations of Lumen Technologies (LUMN), which are the subject of a pending acquisition by Apollo-managed funds (APO).

16:08 EDT Match Group files lawsuit against Google over unlawful billing mandates - Match Group (MTCH) companies, including those that operate the dating apps Tinder, Match, OkCupid, and several others, sued Google (GOOG, GOOGL) over its strategic manipulation of markets, broken promises, and abuse of power in requiring Match Group to use Google's billing system to remain in the Google Play Store. Google's requirement will eliminate user choice on Match Group apps and increase costs to consumers by allowing Google to charge Match Group an arbitrary and discriminatory tax of 15% on all subscriptions and up to 30% on all other in-app purchases, amounting to hundreds of millions of dollars in inflated "fees," while monetizing the personal data of billions of digital app users. Google has monopolized the Google Play Store and is now abusing its power. The lawsuit, filed in the U.S. District Court for the Northern District of California, alleges that Google has violated Sections 1 and 2 of the Sherman Act, the California Cartwright Act, the California Unfair Competition Law, and California tort law through its unlawful mandate requiring select app developers to exclusively use Google Play Billing to process payments.

16:06 EDT Kura Sushi CFO Steven Benrubi to retire - Kura Sushi USA announced that Steven Benrubi, the company's CFO has notified the company of his decision to resign as CFO and retire. Benrubi's CFO resignation will be effective on the earlier of August 1, or when his successor is named, to ensure a smooth transition. The company has initiated a search process to identify his successor.

16:06 EDT Quantum-Si names Patrick Schneider as president and COO - Quantum-Si Incorporated announced the appointment of Patrick Schneider, Ph.D., as President and COO. Schneider will succeed Michael McKenna, Ph.D., who will remain as Executive Vice President, Product Development and Operations. "We have made substantial progress towards launching the world's first true next generation protein sequencing system and I am thrilled to work with Patrick to raise the probability of our near-term and long-term success," said Jonathan Rothberg, Ph.D., Interim Chief Executive Officer, Founder and Executive Chairman of Quantum-Si. "Patrick brings more than two decades of life science senior leadership experience and I am excited to be able to pass the day-to-day leadership of this gifted team to him as we execute our ambitious plans to transform the proteomics landscape." Schneider joins Quantum-Si from MilliporeSigma, where he most recently served as Senior Vice President of Strategy, Business Development and Innovation, and Chair of the Life Science Innovation Board.

16:04 EDT Praxis Precision Medicines expects cash to fund operations into Q3 of 2023 - As of March 31, 2022, Praxis had $222.5 million in cash, cash equivalents and marketable securities, compared to $275.9 million in cash, cash equivalents and marketable securities as of December 31, 2021. This decrease of $53.4 million primarily reflects cash used in operations of $54.1 million during the three months ended March 31, 2022. The Company's cash, cash equivalents and marketable securities as of March 31, 2022 are expected to fund operations into the third quarter of 2023.

16:04 EDT Origin Materials sees FY22 adjusted EBITDA loss up to ($36M) - Capital spending is now expected to be up to $175M.

16:03 EDT ALX Oncology expects cash to fund operations through mid-2024 - Cash, cash equivalents and investments as of March 31, 2022 were $341.7 million. ALX Oncology believes its cash, cash equivalents and investments are sufficient to fund planned operations through mid-2024.

16:00 EDT TherapeuticsMD trading resumes

15:33 EDT NYSE to commence delisting proceedings against Armstrong Flooring - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Armstrong Flooring - ticker symbol AFI - from the NYSE. NYSE Regulation reached its decision that the company is no longer suitable for listing after the company filed a petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on May 9. As disclosed by the company in its Form 8-K submitted to the SEC on May 9, holders of the company's equity securities will likely be entitled to little or no recovery on their investment, NYSE Regulation stated.

13:36 EDT Pharming Group NV (ADS) trading halted, volatility trading pause

13:02 EDT Blackstone announces former Zynga COO Matthew Bromberg as senior advisor - Blackstone (BX) announced the appointment of Matthew Bromberg, former COO at Zynga (ZNGA), as a Senior Advisor. Bromberg will advise across Blackstone's businesses, with a focus on Blackstone Growth, the company said in a statement.

12:56 EDT Everbridge comments on proxy advisor recommendations - Everbridge issued following statement regarding the reports issued by proxy advisory firms Glass Lewis & Co. and Institutional Shareholder Services: "We welcome Glass Lewis' recommendation that shareholders vote "FOR" all of our experienced and highly qualified director nominees. We also appreciate ISS's recommendations that shareholders vote "FOR" each of Richard D'Amore, Alison Dean, David Henshall, Kent Mathy, Simon Paris and Sharon Rowlands. We agree with ISS's view that the execution of the Board's strategic initiatives to enhance value, combined with the identification of a new CEO, has the potential to restore value for the benefit of all shareholders. We also note ISS's statement that Ancora's objective of an immediate sale may not be consistent with the interests of long-term shareholders. However, we strongly disagree with elements of ISS's report, notably the recommendation to withhold from selected directors due to challenges associated with the integration of assets that we acquired in 2021 and the departure of our former CEO, which have both impacted our valuation. Everbridge has a track record of successful acquisitions that have expanded our product portfolio and geographic reach. We believe the acquisitions in 2021 were strategic and will increasingly contribute to Everbridge's business over the long-term... We believe that a vote "FOR" all Everbridge director nominees will help retain a board that is highly qualified and possesses the proper balance of relevant business and industry experience, a range of both fresh and long-term perspectives, and is critical to the stability of the business and the success of our operational initiatives underway. Ancora's campaign to withhold votes from our directors in support of its sole objective of an immediate sale at a valuation trough is an attempt to impede the Board's ability to exercise strategic optionality in the best interests of all shareholders, without the potential benefit of our value-enhancing initiatives."

12:31 EDT Philip Morris confirms discussions with Swedish Match regarding potential offer - Philip Morris International (PM) confirmed, in response to recent market speculation, that discussions are ongoing between PMI and Swedish Match AB (SWMAY) regarding a potential offer for the company. The discussions are in progress and it is uncertain whether an offer will be made, the company said in a statement. PMI intends to make no further comment regarding the discussions unless and until it is appropriate to do so.

12:22 EDT Swedish Match confirms takeover talks with Philip Morris - The board of Swedish Match (SWMAY) has noted the recent speculation and confirms that discussions with Philip Morris (PM) regarding a possible public takeover offer for Swedish Match are ongoing. "There can be no certainty that an offer will be made, nor as to the terms of any such potential offer," the company said in a statement.

12:01 EDT Palantir falls -20.8% - Palantir is down -20.8%, or -$1.98 to $7.50.

12:01 EDT Textron Aviation announces first delivery of new Cessna SkyCourier to FedEx - Textron Aviation (TXT) announced the first delivery of the Cessna SkyCourier twin utility turboprop to FedEx Express (FDX). This is the first of 50 freighter aircraft that global logistics firm FedEx Express ordered as the Cessna SkyCourier's launch customer. The clean-sheet aircraft achieved Federal Aviation Administration type certification in March 2022. "FedEx took delivery of its first Cessna in the mid-1980s and the two companies have had a collaborative relationship over the four decades since," said Ron Draper, president and CEO, Textron Aviation. "We're thrilled to deliver this aircraft that will help FedEx serve its customers more efficiently as it is designed with the option to carry industry-standard prepacked cargo containers. We believe many other air freight, passenger and special mission operators also will benefit from the winning combination of low operating costs and unparalleled lift capacity that the new Cessna SkyCourier brings to the market."

12:00 EDT Daily S&P Biotech Bear 3x Shares rises 15.4% - Daily S&P Biotech Bear 3x Shares is up 15.4%, or $9.81 to $73.51.

12:00 EDT ProShares UltraShort Bloomberg Natural Gas rises 17.3% - ProShares UltraShort Bloomberg Natural Gas is up 17.3%, or $1.18 to $8.00.

11:29 EDT United States temporarily suspends 232 tariffs on Ukrainian steel - Secretary of Commerce Gina Raimondo announced the United States of America will be temporarily suspending 232 tariffs on Ukrainian steel for one year. "Ukraine's steel industry is uniquely important to the country's economic strength, employing 1 in 13 Ukrainians with good-paying jobs...Creating export opportunities for these mills is essential to their ability to continue employing their workers and maintaining one of Ukraine's most important industries," the agency said in a statement. Publicly traded companies in the steel space include AK Steel (AKS), ArcelorMittal (MT), Nucor (NUE), Steel Dynamics (STLD), TimkenSteel (TMST) and U.S. Steel (X). Reference Link

11:07 EDT Advent Technologies announces technology assessment agreement - Advent Technologies Holdings announced the signing of a technology assessment agreement with a second large global automotive manufacturer. With a common goal of sustainability and the faster decarbonization of the U.S. automotive industry, Advent said in a statement that it is supporting efforts to advance innovative fuel cell technology as a sustainable and efficient option for achieving carbon neutrality. More specifically, Advent will provide assistance, through: Supplying Membrane Electrode Assemblies for testing, evaluation, and optimization under the collaborator's conditions. Providing support on MEA operational parameters while the collaborator supplies feedback to Advent on performance and durability. Sharing technical know-how for fuel cell stacks, proprietary HT-PEM technology, and leveraging HT PEM for advanced cooling systems.

11:01 EDT Twitter down 4% to $47.89 after Hindenburg releases short report

10:59 EDT Nuvectis Pharma Inc trading halted, volatility trading pause

10:37 EDT Wolters Kluwer partners with Clarivate to distribute Darts-ip in the U.S. - Wolters Kluwer Legal & Regulatory U.S. (WTKWY) announced its strategic partnership with Clarivate (CLVT) to sell Darts-ip to its U.S. law firm customers. Darts-ip is a comprehensive, searchable global IP cases solution that provides users with Al-powered analytics to unlock valuable insights to understand trends, spot opportunities, and support confident IP business solutions.

10:34 EDT Arrowhead breaks ground on manufacturing facility in Wisconsin - Arrowhead Pharmaceuticals held a groundbreaking ceremony in Verona, WI, on the site which will house a new approximately 160,000 square foot drug manufacturing facility and an approximately 125,000 square foot laboratory and office facility to support process development and analytical activities. The Company also announced that it received awards for up to $16N in tax increment financing from the city of Verona, and up to $2.5M in refundable Wisconsin state income tax credits from the Wisconsin Economic Development Corporation as incentives to invest in the local community and create new jobs. Completion of the lab and office space is anticipated in 2023 and completion of the manufacturing facility is expected in 2024.

10:02 EDT Arvinas, GNS Healthcare announce neuroscience drug discovery collaboration - GNS Healthcare announced a collaboration with Arvinas to generate insights to help accelerate drug development for neurodegenerative diseases. Under the terms of the agreement, Arvinas will leverage GNS' Gemini Virtual Patient models to better understand the biology of the underlying disease, how it progresses, and how potential drugs might perform at the individual patient level. "This will help Arvinas researchers discover and prioritize novel drug targets and drug candidates, simulate clinical trials to better understand drivers of diseases for various clinical outcomes, better select patients for clinical trials, and help determine which treatments are most effective for given patient types," the company said. Angela Cacace, Ph.D., Senior Vice President of Neuroscience & Platform Biology at Arvinas, added, "We believe this collaboration will provide novel insights and will help us understand the underlying mechanisms of complex neurodegenerative diseases to inform our discovery and development efforts with the aim of improving patient outcomes."

10:00 EDT TEN, Ltd. falls -13.9% - TEN, Ltd. is down -13.9%, or -$1.82 to $11.31.

10:00 EDT Energy Vault falls -26.4% - Energy Vault is down -26.4%, or -$3.70 to $10.32.

10:00 EDT L.S. Starrett Co rises 11.2% - L.S. Starrett Co is up 11.2%, or 73c to $7.22.

09:59 EDT Tyson Foods says making progress in chicken segment, but more work to do - Says demand for chicken is strong. Says operating under "heightened measures" in certain areas of the country. Expects beef demand to remain strong from a global perspective. Seeing "unprecedented inflation." Expects inflationary pressures in 2H22.

09:47 EDT TEN, Ltd. falls -11.8% - TEN, Ltd. is down -11.8%, or -$1.56 to $11.57.

09:47 EDT Palantir falls -19.3% - Palantir is down -19.3%, or -$1.83 to $7.65.

09:47 EDT BellRing Brands rises 8.9% - BellRing Brands is up 8.9%, or $2.18 to $26.60.

09:42 EDT DecisionPoint Systems Inc trading halted, volatility trading pause

09:39 EDT BetMGM named exclusive sports betting partner of Houston Astros - BetMGM, a leading sports betting and iGaming operator, today announced that the company now is the exclusive Sports Betting Partner of the Houston Astros. This marks BetMGM's first relationship in Texas. Under the agreement, BetMGM signage will be prominently featured at Minute Maid Park. This includes a permanent outfield wall sign and rotational promotional messaging behind home plate. Astros fans will have the opportunity to participate in a variety of VIP experiences exclusive to BetMGM customers. These include throwing out the first pitch, on-field access to batting practice, and VIP getaways for away games, among others. BetMGM and the Astros also will team up to offer special betting promotions for BetMGM customers in Louisiana.

09:36 EDT Entourage Health announces issuance of cease trade order - Entourage Health announced that the Ontario Securities Commission has issued a Cease Trade Order as a result of the Company not filing its financial statements for the year ended December 31, 2021 and the related management's discussion and analysis and CEO and CFO certifications by May 2, 2022, being the date that such filings were due under applicable Canadian securities laws. The cause of the delay was not material to the Company or its operations and was due primarily to the Company's new external auditor needing additional time to complete the required procedures. The Company has completed the filing of the Annual Filings and anticipates that the CTO will be revoked and trading of the Company's common shares will resume in the coming days.

09:33 EDT U.S. Bancorp announces $100B Community Benefits Plan - U.S. Bancorp announced a five-year community benefits plan, developed in coordination with the National Community Reinvestment Coalition and the California Reinvestment Coalition, as part of the planned acquisition of MUFG Union Bank. The CBP continues and expands the important work underway by both organizations to build and support equitable access to capital for the communities we serve. The CBP builds on U.S. Bank's previously announced U.S. Bank Access Commitment efforts and integrates existing community impact efforts from MUFG Union Bank. A majority of the commitments, 60% of the total, will support efforts in California, the state most impacted by the acquisition. Commitments in the CBP are subject to the successful completion of full systems and staffing conversions to a unified bank platform.

09:23 EDT Alkaline Water closes public offering of common stock - The Alkaline Water Company announced the closing of its public offering of 8,333,334 shares of common stock at a public offering price of $0.60 per share. The gross proceeds of the offering were approximately $5 million before deducting underwriting discounts, commissions and offering expenses. In addition, the Company granted the underwriters a 45-day option to purchase additional shares of common stock, representing up to 15% of the number of the shares, solely to cover over-allotments, if any, which would increase the total gross proceeds of the offering to approximately $5.75 million, if the over-allotment option is exercised in full, before deducting underwriting discounts, commissions and offering expenses. The common stock is trading on The Nasdaq Capital Market under the symbol "WTER". Aegis Capital Corp. acted as the sole book-running manager for the offering.

09:20 EDT Principal Solar, Triad Pro to collaborate on EV energy storage solutions - Principal Solar announced that it has executed a definitive research and development agreement with Triad Pro Innovators. The Agreement establishes a relationship for cooperative research and development between Principal and Triad Pro for the purpose of creating new power storage solutions for the Electric Vehicle industry. Potential applications for solutions created under the agreement include use in Principal's client and portfolio company products, specifically its fleet-focused heavy electric vehicle conversions and hybrid-electric powertrains, which require unique capabilities supporting continuous operation with long charging cycles - capabilities underserved by existing battery technologies.

09:19 EDT Nokia launches cybersecurity-focused testing lab in US - Nokia announced the launch of its Advanced Security Testing and Research, ASTaR, lab, located in Dallas, Texas. It is the first end-to-end 5G testing lab in the U.S. focused solely on cybersecurity. As the central lab dedicated solely to security forensics and research, ASTaR will use and develop cutting-edge tools and techniques to assess the security resilience of 5G networks, as well as their associated software, hardware and applications. ASTaR will then use these assessments to address emerging security threats, and lab researchers will engage with the cybersecurity community to identify emerging threat vectors and potential vulnerabilities. Nishant Batra, Chief Strategy and Technology Officer, Nokia, said: "5G will enable countless new services for consumers, government and businesses, and the industry must be hyper-vigilant in ensuring these 5G ecosystems are secure. To demonstrate our leadership and commitment to security, Nokia will be the first to inaugurate a lab in the U.S. with the singular mission of identifying and preventing cybersecurity attacks. ASTaR lab will be an ideal testing ground to assess security in the larger context of network use and abuse scenarios."

09:18 EDT Telstra appoints Noah Drake as president for the Americas - Telstra has named Noah Drake as President for the Americas, responsible for leading the company's future direction within the region. Drake will oversee all sales and business operations, playing a key role in further expanding Telstra's portfolio of technology solutions and continuing to accelerate strategic partnerships. Most recently, he led Telstra's Customer Solutions and Architecture group, directing a specialized team of professionals working with customers to harness the full capabilities of Telstra's products and services.

09:17 EDT Red Hat collaborates with UK Department for Work and Pensions - Red Hat has collaborated with the UK's Department for Work and Pensions to accelerate its benefits claims processes with an open hybrid cloud strategy, providing critical financial assistance for its 22 million claimants. Working with Red Hat to deploy Red Hat Ansible Automation Platform, Red Hat Enterprise Linux, and Red Hat OpenShift, the DWP has reduced deployment times for new services from around nine to 10 hours to just 15 minutes - a reduction of up to 97.5%.

09:14 EDT Rent-A-Center publishes inaugural sustainability report - Rent-A-Center announced the issuance of its inaugural Sustainability Report, which provides the first steps in developing and implementing a strategy focused on environmental, social and governance performance by highlighting our key initiatives that manage the evolving risks and opportunities across all areas of the business. "Our mission at Rent-A-Center has always been to increase access to a better quality of life for people underserved by mainstream financial systems. Our commitment to making a positive impact goes beyond our customers. It applies to co-workers, the communities we operate in, shareholders, and society broadly. I am proud to say our inaugural Sustainability Report shows this commitment and our focus on business practices that minimize harm and maximize positive impacts on people and the planet moving forward," said Mitch Fadel, Chief Executive Officer.

09:13 EDT Comcast announces additional efforts for Affordable Connectivity Program - Comcast announced new developments in its efforts to increase awareness and help people take advantage of the life-changing program that provides $30 each month toward their connectivity needs. People will soon be able to visit 500+ Xfinity Stores nationwide to sign up for Internet Essentials Plus, a service that includes 100 Mbps speed, a cable modem, access to millions of WiFi hotspots, and unlimited data for $29.95 per month. During their visit, customers can also learn more about how to enroll in ACP to get Internet service for free. Comcast is also equipping tens of thousands of call center representatives to help customers sign up for Internet Essentials Plus and educate about ACP. Any Xfinity customer across all Comcast's markets who qualifies for ACP can apply their $30 credit toward their monthly Internet and/or Xfinity Mobile bill. In addition, through Project UP, Comcast's $1B commitment to advance digital equity and help build a future of unlimited possibilities, the company is partnering with its network of thousands of non-profit organizations in communities across the country to increase awareness of, and participation in ACP, while also addressing broadband adoption issues like the lack of digital skills. In the last six months, Comcast has distributed well over $1 million dollars in grants to support dozens of local non-profits affiliated with the Hispanic Federation and the National Urban Indian Family Coalition, as well organizations such as NPower, with plans to invest millions more throughout the year.

09:12 EDT BOS Better Online Solutions purchases warehouses, office space for $1.9M - BOS Better Online Solutions announced that it has purchased 546 sqm of offices, 495 sqm of warehouses and nine parking spots in Rishon Le Zion, Israel. The purchased real-estate is part of the facilities BOS has been leasing in Rishon Lezion. BOS shall pay for this acquisition NIS 6.5M, or approximately $1.9M. Eyal Cohen, BOS' CEO, stated: "BOS leases 2,131 sqm in Rishon Lezion and 710 sqm in Rosh Hain, both in Israel. Our monthly lease expense for the facilities we acquired amounts to $10,000. This lease expense, and our expectation that it shall increase significantly upon lease renewal, led us to pursue the acquisition. We plan to finance the purchase by a long-term bank loan in the amount NIS 4.5 million in addition to cash we have at hand."

09:11 EDT Embark Technology completes autonomous testing in winter conditions - Embark Trucks announced the successful completion of on-road testing in snowy conditions in Montana. The testing, which Embark announced earlier this year, was conducted to demonstrate the performance and safety of Embark's patent-pending Vision Map Fusion technology in geographies that experience severe winter weather. Results from the testing demonstrate that in approximately 90% of runs through the snowy conditions under study - which could result in delays for HD map-based autonomous driving systems - VMF should operate successfully, or pause and resume travel within acceptable shipper delivery windows. "The testing and weather analysis show significant technical and commercial promise: Embark's testing and performance review indicated that VMF worked within tolerance thresholds for safe operation in snowfall rates up to one-sixth inch per hour and with snow accumulation of 1 inch on the road over 3 hours, conditions that cover the vast majority of snowy weather based on Embark's analysis," the company said. The favorable test results represent a milestone in the development of autonomous trucking technology, as well as a major achievement for Embark made possible with VMF. Embark plans to continue to study the impact of snowy conditions on other elements of the Embark Driver. "When we set out to develop our autonomous truck solutions, we planned to create a system that is capable of operating safely across America in all kinds of road conditions, broadening our scope to serve parts of the country that may be limited by snow or inclement weather," said Alex Rodrigues, CEO of Embark. "While we continue to focus on our existing commercialization timeline, the validation of our VMF technology for use in northern states and regions that regularly experience seasonal snowy weather will prepare us for long-term deployments and growth, and help us provide the most flexible solution possible for our carrier partners."

09:10 EDT Cloudflare collaborates with Deno, individual core contributors of Node.Js - Cloudflare announced that it is collaborating with Deno and individual core contributors of the Node.js open source project, bringing together three of the largest JavaScript environments, to give developers flexibility and choice while creating the standards of the future of edge computing. By collaborating around a common set of standards, the effort will aim to ensure code developed in one environment will work in another. Any developer will be able to write and run code conforming to the set of standards-and easily transfer it-between Cloudflare Workers, Deno, and Node.js seamlessly and without the need to rewrite an application.

09:09 EDT Electronic Arts, Midddle-earth Enterprises partner on LOTR mobile game - Electronic Arts has partnered with Middle-earth Enterprises, a division of The Saul Zaentz Company, on the development of a new free-to-play mobile game. The Lord of the Rings: Heroes of Middle-earth is a Collectible Role-Playing Game that brings the fantasy and adventure of The Lord of the Rings to existing fans and new audiences alike in a strategic, social-competitive experience. The Lord of the Rings: Heroes of Middle-earth is the newest addition to EA's expanding mobile portfolio as the company continues delivering exceptional experiences and top live services, reaching more players on more platforms around the world.

09:07 EDT Red Hat, Accenture expand alliance to accelerate hybrid cloud innovation - Red Hat (RHT) and Accenture (ACN) have expanded their nearly 12 year strategic partnership to further power open hybrid cloud innovation for enterprises worldwide. The companies are jointly investing in the co-development of new solutions to help organizations more seamlessly navigate a multi- and hybrid cloud world, define their strategy, and accelerate their pace of innovation to get to value faster. With the combination of Accenture Cloud First and Red Hat OpenShift, organizations are better equipped to embrace the cloud continuum - a range of capabilities, from public to private to edge computing, all connected by modern networks and built with a zero-trust security mindset - to accelerate enterprise reinvention. A hybrid solution brings the public cloud benefits of innovation, speed, consumption and scale with private cloud advantages of regulatory compliance, performance and data gravity.

09:05 EDT Nuvei partners with Bibox to enable better access to cryptocurrencies - Nuvei announces its partnership with Bibox, an AI-driven digital asset trading platform. The collaboration will provide Bibox customers with a unified trading experience by enabling easy access to cryptocurrencies through the Simplex by Nuvei on-ramp solution. Following the integration, Bibox users will have seamless checkout experience when purchasing cryptocurrencies using credit and debit cards, Apple Pay, SEPA or SWIFT transfers. The partnership with Nuvei ensures secure user journeys while granting Bibox full chargeback and fraud protection guarantee.

09:05 EDT BNP Paribas, Northland Power partner with Export Development Canada - BNP Paribas, announced that it has recently closed an amendment to add sustainability-linked incentives to its Letter of Credit Facility with renewable power producer, Northland Power. Northland converted its $50 million bilateral LC Facility with BNP Paribas to a sustainability-linked agreement, which is backed by Canada's export credit agency, Export Development Canada. This marks EDC's first sustainability-linked LC facility, which will support Northland's current and future renewable energy growth strategy, including offshore wind projects across the globe. EDC's bonding solutions, offered in partnership with private sector financial institutions, help free up the working capital that companies need to operate. This LC facility also represents Northland's second sustainability-linked credit facility, after Northland renewed, extended and converted its CAD $1 billion revolving credit facility to a sustainability-linked loan structure in September 2021. The SLL structure aligns with Northland's Green Financing Framework, unveiled in the first half of 2021. The five-year RCF features a pair of KPIs with targets linked to increasing Northland's renewable energy generation and reducing carbon intensity. BNP Paribas acted as a co-sustainability structuring agent on the SLL.

09:04 EDT Sonoco announces price increase for paperboard tubes, cores - Sonoco announced it will raise the price for all paperboard tubes and cores by a minimum of 6 percent, effective with shipments in the United States and Canada on or after June 10, 2022. "Ongoing market tightness and additional inflationary cost pressures from rising paperboard prices, our primary raw material, along with higher labor rates, make this increase necessary," said Doug Schwartz, Division Vice President and General Manager, North America Tubes and Cores. "Despite these supply chain pressures, we remain committed to maintaining the quality and service that our customers are accustomed."

09:03 EDT KeyCorp acquires debt advisory company GradFin - KeyBank has acquired GradFin, a Public Service Loan Forgiveness counseling provider. Founded in 2015 and based in Philadelphia, Pennsylvania, GradFin offers high-touch advisory solutions for individuals seeking assistance with student loan debt. GradFin experts provide one-stop-shopping for borrowers seeking debt solutions, with a particular focus on working with financial advisors and their clients.

08:59 EDT Echelon Insurance deploys Guidewire InsuranceSuite - Echelon Insurance and Guidewire announced that Echelon has deployed InsuranceSuite and DataHub as its new underwriting, policy administration, claims, billing, and enterprise-wide data management solution. Guidewire PartnerConnect Consulting members Cognizant and Infosys supported the implementation project. Echelon deployed the Guidewire products to its Personal Auto and IRCA lines of business in the province of Ontario and is in the early stages of expanding to those lines of business across Canada. Future rollouts will focus on the company's other Specialty commercial lines of business. Echelon also deployed SmartCOMM from Smart Communications for customer communications management. Guidewire is a reseller of SmartCOMM for Smart Communications, a Guidewire PartnerConnect Solution member.

08:58 EDT Blue Apron expects to return to positive y/y revenue growth in 2Q22

08:53 EDT Blue Apron expects Q1 to be high water mark of quarterly spend this year

08:53 EDT Newegg Commerce enrolls as sole sponsor of hackIMSA - Newegg announced its exclusive, sole sponsorship of hackIMSA, a 48-hour virtual Illinois statewide high school hackathon, taking place May 13-15. The hackathon is the first of its caliber in Illinois. Developed and hosted by Code Society, a computer science club at the Illinois Mathematics and Science Academy, a top-rated, magnet high school in Aurora, Ill., hackIMSA is a virtual sprint programming competition for computer science students from high schools throughout the state.

08:51 EDT Blue Apron exited quarter with more normalized margin rate

08:50 EDT Blue Apron has more customers now than at end of Q1

08:50 EDT Sports Ventures Acquisition, DNEG file amended proxy statement on combination - DNEG and Sports Ventures Acquisition Corp., a publicly-traded special purpose acquisition company, announced they have filed with the U.S. Securities and Exchange Commission an amended proxy statement with respect to their proposed business combination. The filing can be found here. The Business Combination with Sports Ventures is subject to customary closing conditions, including the approval of Sports Ventures' stockholders, and is expected to be consummated in the first half of 2022. Upon the closing of the Business Combination, the Company will operate under the DNEG name and is expected to be listed on NASDAQ trading under the new symbol "DNGG".

08:47 EDT Vivaro Telecom selects Fujitsu for DWDM Network - Fujitsu Network Communications announced that Vivaro Telecom has selected the 1FINITY platform for a greenfield, next-generation DWDM network deployment in Texas to enhance high-speed data services between the U.S. and Mexico. The open, modular platform offers scalable 400G wavelengths to support the ever-increasing bandwidth needs of today's applications, including those that support remote working.

08:46 EDT Lucid Diagnostic in participating provider pact with MediNcrease Health Plans - Lucid Diagnostics and majority-owned subsidiary of PAVmed announced that its wholly-owned CLIA-certified and CAP-accredited laboratory, LucidDx Labs has entered into a participating provider agreement with MediNcrease Health Plans a national, directly-contracted, multi-specialty PPO provider network with over 8 million lives covered through its clients and payers, which include regional and national health plans, insurance companies, third party administrators, self-insured employer groups, municipalities, unions, and other entities involved in the management of medical claims. MediNcrease's innovative payment solutions offer important benefits to both payers and providers. Pursuant to the agreement, persons covered by MediNcrease clients and payers will have in-network access to Lucid's EsoGuard DNA test, the first and only commercially available test capable of serving as a widespread tool to prevent esophageal cancer deaths through the early detection of esophageal precancer in at-risk chronic heartburn patients. The agreement provides rates of reimbursement as a percent of charges for services rendered to such covered persons by LucidDx Labs, including performance of the EsoGuard test. "We are excited to join the MediNcrease national provider network and offer in-network access to EsoGuard esophageal cancer prevention testing to millions of persons

08:45 EDT ICE launches Nature-Based Solutions carbon credit futures contract - Intercontinental Exchange announced that it has launched a Nature-Based Solutions carbon credit futures contract. The NBS future, which trades under the contract code NBT, physically delivers Verified Carbon Unit credits certified under Verra's Verified Carbon Standard Agriculture, Forestry and Other Land Use Projects with Climate, Community and Biodiversity Certification, with vintages between January 1, 2016, to December 31, 2020. Each NBS futures contract is equal to 1,000 carbon credits, where each credit is equal to the removal or reduction of one metric ton of greenhouse gas emissions achieved by projects that preserve and maintain natural ecosystems. ICE has listed NBS futures expiries in December 2022, December 2023, and December 2024. Participants supporting the contract include Chevron Products Company, a division of Chevron U.S.A. Inc., EDF Trading, Elbow River Marketing Ltd. a fully owned Parkland Fuel subsidiary, the Macquarie Group, Shell, Trafigura, Vertree Partners and Vitol.

08:44 EDT Blue Apron looks forward to announcing similiar partnerships in coming months

08:42 EDT Motorcar Parts unit D&V gets inverter test system order from Taiwan's ARTC - Motorcar Parts of America announced its wholly owned subsidiary D&V Electronics has received an order for an automated inverter test system from Taiwan's Automotive Research & Testing Center ARTC to support the development of electric vehicles and related technologies. Terms of the contract were not disclosed. The traction inverter is a critical component in an electric vehicle's powertrain system, designed to convert direct current from the battery to alternating power suitable for driving the electric motor. "This prestigious research and testing center is committed to innovation and safety, including the development of green transportation solutions, based on internationally recognized testing standards and certification, and we are proud to have been selected by ARTC after a rigorous evaluation process," said Selwyn Joffe, chairman, president and chief executive officer of Motorcar Parts of America, Inc.

08:39 EDT Navitas Semiconductor announces 50 millionth GaN shipment with vivo - Navitas Semiconductor announced the achievement of 50,000,000 units shipped - with zero reported GaN-related field failures.

08:39 EDT NYSE to suspend trading in Cypress Environmental, commence delisting - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common units of Cypress Environmental Partners, from the NYSE. Trading in the Company's common units will be suspended immediately. NYSE Regulation reached its decision that the Company is no longer suitable for listing pursuant to Listed Company Manual Section 802.01D. The Company filed a petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas on May 8, 2022 and it is expected that the contemplated restructuring will result in the Company's common units having no value. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company's securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff's decision.

08:38 EDT Safe-T issues letter to shareholders from CEO Daniel - Safe-T Group issued the following letter to shareholders. "To the Safe-T Group Shareholders: I write to you today to share my thoughts on the developments of the past few months, but more importantly, about the exciting future we are now pursuing for our company... Safe-T successfully began its strategic transition into a consumer cybersecurity and privacy company, expanding beyond our existing enterprise business while delivering impressive top-line growth. As we announced in mid-April, we expect another record first quarter 2022 revenues of approximately $4 million, representing growth of ~200%, driven in large part by the success of our shift into the consumer business and our customer acquisition programs which have attracted new subscribers... Relying on our solid foundation we created in the Enterprise business, we initiated a strategic pivot, expanding from selling unique cybersecurity products to enterprise and governmental customers into the vast consumer market which accelerated last year with the successful acquisition of CyberKick. This transition has had several impacts on Safe-T, most notably, 1) a more concerted shift in our entire business model, both in the Consumer and Enterprise businesses, away from one-time perpetual licenses towards a recurring, subscription-based model, and 2) the necessity of making ongoing investments into customer acquisition.... It is important to note that while the consumer business will become the dominant driver of our growth, we are still pursuing our enterprise business. In addition to growing recurring revenues in our Enterprise Privacy business, we have executed new partnerships with established organizations such as TerraZone and DreamVPS, allowing us to leverage their expertise and installed bases of customers to drive marketing and sales of our enterprise cybersecurity products...Our confidence is based in our proven ability to produce triple-digit growth over the past two years with a business model that has the potential to continue delivering impressive results month-over-month, and quarter-over-quarter. We believe in our ability to produce at least 50% revenue growth on an annual basis and efficiently manage operating costs, assisting us to reach profitability while driving towards a $50 million revenue target for 2025...We are confident in the assets we have built, our growing customer base, our unique technologies, and a recurring revenue business model capable of producing strong growth, all of which will allow us to recognize the true value of our company... Sincerely, Shachar Daniel, Chief Executive Officer."

08:38 EDT Blue Apron started rolling out small per serving price increases this month

08:37 EDT GoodRx names former Uber grocery, new verticals chief Raj Beri as COO - GoodRx (GDRX)announced it has made key leadership appointments to support the company's scaling business and accelerate innovation to bring more affordable and convenient healthcare to consumers across the country. Raj Beri will join GoodRx as the company's first ever Chief Operating Officer from Uber (UBER), where he served as Vice President of Grocery and New Verticals, overseeing the company's non-restaurant and last mile delivery businesses across global markets. With more than 20 years in the business operations space, Raj will lead continued growth and expansion at GoodRx, while helping increase value across the prescriptions business.

08:35 EDT Acer Therapeutics announces agreement with FDA on SPA for Phase 3 trial - Acer Therapeutics announced it has reached agreement with the U.S. Food and Drug Administration under a Special Protocol Assessment for its pivotal Phase 3 DiSCOVER clinical trial of EDSIVO for the treatment of patients with COL3A1-positive vascular Ehlers-Danlos Syndrome. In April 2022, FDA granted celiprolol Breakthrough Therapy designation in the U.S. The SPA agreement is a process through which sponsors may seek agreement with FDA on the design and size of certain clinical trials, clinical studies, or animal studies. Agreement on Acer's Phase 3 trial design indicates concurrence by FDA with the adequacy and acceptability of specific critical elements of the overall protocol design that could support a future regulatory submission and marketing application if the trial results meet the agreed-upon criteria.

08:34 EDT Virgin Orbit announces next launch 'Straight Up' - Virgin Orbit has entered flight preparation mode for its forthcoming launch, Straight Up, that will support the United States Space Force's STP-28A mission. After departing Virgin Orbit's Long Beach rocket factory on Thursday, April 28, 2022, the rocket arrived at the Mojave Air and Space Port. It will support the Rocket Systems Launch Program and will carry payloads for the Department of Defense Space Test Program. Integration testing with airplane and ground equipment will take place followed by a full launch rehearsal and final mating to the customized 747 that serves as Virgin Orbit's flying and fully re-usable launch pad and mobile mission control room. Launch is expected no earlier than June 29. The launch window is projected to open at 8 pm local time, representing the first night mission for the responsive launch company. The target orbit is approximately 500km above the Earth's surface at 45 degrees inclination - an orbit that no other system has reached from the West Coast. Playing a key role in the Straight Up launch will be the Virgin Orbit National Systems team, which has developed and provided services to the national security community, focused on defense and the protection of the United States and its allies through Virgin Orbit's responsive space capabilities. To date, Virgin Orbit has launched three successful back-to-back launches, including eight DoD Science & Technology demonstrations across two flights.

08:34 EDT CACI gets$138M task order to provide TACCOM support to ICE - CACI International announced that it won a $138M single-award mission expertise task order to continue to provide Tactical Communications, TACCOM, engineering and maintenance support services to U.S. Immigration and Customs Enforcement ICE. The TACCOM program provides critical voice communications capabilities for the ICE mission. Awarded under the TACCOM II indefinite delivery, indefinite quantity contract, this task order significantly expands both the scope and size of the company's support to ICE. Under this task order, awarded in the first quarter of CACI's fiscal year 2022, CACI will provide system lifecycle development and maintenance activities, in accordance with the Department of Homeland Security's system engineering lifecycle. As part of this effort, CACI will provide preventative and corrective maintenance for fixed infrastructure sites throughout the U.S. and rapid response for any outages affecting portable and mobile radios used by ICE personnel. CACI will also support the agency's modernization efforts through financial and program management support.

08:33 EDT CVRx receives MR-conditional labeling approval for Barostim system - CVRx has received U.S. Food and Drug Administration approval for magnetic resonance conditional labeling for its Barostim System. The Barostim System now includes instructions to allow for safe MRI scans of the head and lower extremities, meaning heart failure patients implanted with Barostim have more diagnostic options. All Barostim System patients, including those already receiving Barostim therapy, can safely receive an MRI at 1.5T when conditions of use are met. "This is a significant milestone for CVRx, and more importantly, for the heart failure patients benefitting from our therapy," said Nadim Yared, President and CEO of CVRx. "These heart failure patients undergo many physical assessments. This approval expands the diagnostic imaging options available to physicians for these patients, should the need arise."

08:33 EDT Doug Pertz appointed Brink's executive chairman of the board

08:32 EDT RealNetworks receives unsolicited, non-binding proposal from CEO Rob Glaser - RealNetworks announced that it has received an unsolicited, non-binding proposal from Robert Glaser, RealNetworks' Founder, Chairman and CEO to acquire all of the outstanding shares of common stock of RealNetworks not currently owned by Glaser and his affiliates at a purchase price of 67c per share in cash, subject to certain conditions. Glaser, together with his affiliates, currently owns approximately 38% of the outstanding shares of RealNetworks stock. In light of the proposal, the board of directors of RealNetworks has appointed an independent special committee to carefully review and evaluate Glaser's proposal and other available alternatives. The Special Committee is composed of two independent directors of RealNetworks' board of directors, Erik Prusch and Bruce Jaffe. The Special Committee will retain independent financial and legal advisors to consider the proposal. "While this offer initiates a process that will unfold over a period of time, we want to assure all of our agents and clients that business will continue as usual, and we expect there to be no change in the products, services, or support we provide," said Glaser. The Special Committee intends to undertake a prompt review and evaluation of the proposal and other available alternatives with its financial and legal advisors to determine the course of action it believes to be in the best interests of RealNetworks and its stockholders, but there can be no assurance that this process will lead to the approval or completion of any transaction. RealNetworks does not intend to disclose developments regarding this process unless and until the Special Committee and RealNetworks' board of directors have approved a specific transaction or otherwise concluded its review of strategic alternatives.

08:30 EDT Fifth Third sets new operational sustainability targets by 2030 - Fifth Third announced six new operational sustainability targets to be achieved by 2030. These targets build upon the Bank's initial five goals set in 2017, which established the foundation for Fifth Third to reduce the environmental impact in its own operations. The 2017 goals were to purchase 100% renewable power and to reduce its energy use, greenhouse gas emissions, water use and waste sent to landfills by 2022. Fifth Third's new and enhanced operational sustainability targets for 2030 are: Purchase 100% renewable power; Reduce location-based GHG emissions1 by 75%; Reduce energy use by 40%; Reduce potable water use by 50%; Divert 75% of waste from going to landfills; Reduce paper use by 75% and purchase remaining paper from certified sources. Since 2014, Fifth Third has reduced its location-based Scope 1 and Scope 2 emissions by more than 50%. Fifth Third has been carbon neutral for these emissions since 2020 with the purchase of 100% renewable power and verified carbon offsets for the remaining emissions. In addition to announcing these new targets, Fifth Third announces the establishment of a Sustainability Office with the appointment of Mike Faillo as chief sustainability officer. As CSO, Faillo will lead the office and will lead Fifth Third's comprehensive environmental, social and governance strategy, which includes the Bank's climate strategy and sustainable finance initiatives, as well as social and governance reporting. This includes working with the lines of business to develop financial solutions and drive innovation to ensure the transition to a sustainable and inclusive economy.

08:29 EDT ImmunoPrecise Antibodies unit BioStrand secures second VLAIO research grant - Diepe IPA is pleased to share that IPA's subsidiary Biostrand, a Belgian end-to-end multi-omics analysis platform provider, has received a EUR 460,000 round of grant funding from VLAIO the research fund of the Flemish regional government in Belgium. Conditionally awarded in January this year, BioStrand recently satisfied the remaining criteria for the award, which follows an original grant from VLAIO of EUR 235,000 in 2020. Commenting on the latest grant, Dr. Ingrid Brands, General Manager and co-founder of BioStrand, stated, "Thus far, our patented HYFT -based methodology has been applied predominantly to streamline analysis at the syntactic level and combines sequence information with natural language processing. Using the presence, occurrence, and distribution of HYFT patterns, the focus has been on analysis and integration of sequence-based 'syntactical' information. We are now extending the methodology to combine syntactical and structural information and to expand our services portfolio with HYFTbased structural and functional modelling functionalities. By linking HYFTs with the 3D structure of proteins and expanding platform capabilities for AI discovery, we will be able to support an even wider array of applications, including assay development, biomarker discovery, and computer-aided drug design." The strategic objective driving this HYF -based synthesis of syntactical and structural information is to extend BioStrand's technology to encompass the structure of proteins. A key advantage of this blended approach is the detection of protein sequences with similar structures but without high sequence similarity . A primary application for this approach will be in protein structure prediction, with a particular first focus on antibodies as well as G protein coupled receptors GPCRs. This will be extended to cover protein-protein interaction prediction at a later stage.

08:27 EDT CareCloud's Revenue Cycle Services, talkEHR selected by University of Tennessee - CareCloud announced that the University of Tennessee Health Science Center, College of Dentistry Pathology, has selected CareCloud's Revenue Cycle Services and talkEHR to enhance revenues, streamline workflows, and alleviate billing inefficiencies. CareCloud will manage all aspects of billing and collection of professional fees for procedures performed by the University's Department of Oral and Maxillofacial Diagnostic Services (OMDS). OMDS serves as a histologic diagnostic service within the University's College of Dentistry, typically receiving thousands of biopsy cases per year.

08:26 EDT Wolfspeed, Rhombus Energy collaborate for faster EV charging infrastructure - Rhombus Energy Solutions announced that Wolfspeed will supply its EV2flex line of charging infrastructure products with Silicon Carbide MOSFETs, which will offer the products greater efficiency, higher power density and faster charging times. Rhombus' EV2flex infrastructure includes a family of products that enables fast, bi-directional charging and efficient energy storage. Vehicle-to-grid V2G charging supports power flow between the grid and the car, allowing a charged vehicle to become a power source when needed and ultimately enhancing the stability of the power grid. "Wolfspeed has unequivocally demonstrated the high value of their Silicon Carbide MOSFETs and we are pleased to partner on advanced technology products," said Deanne Davidson, senior vice president and general manager of Rhombus Energy Solutions. "As Rhombus continues to be the leading provider for V2G charging systems, Wolfspeed's Silicon Carbide MOSFETs are a critical component for Rhombus to meet the demands in the growing DC fast-charging market for EVs." "

08:25 EDT Tyson Foods targets $1B+ in productivity gains by end of FY24 - Now expects 40%+ delivered by the end of FY22.

08:25 EDT Immix Biopharma announces share repurchase program - Immix Biopharma announced that its board of directors has authorized a share repurchase program to acquire up to $1M of the Company's common stock. The Company may purchase common stock on the open market, through privately negotiated transactions, or otherwise, in compliance with the rules of the United States Securities and Exchange Commission and other applicable legal requirements. "We are confident that with the $24.2 million gross proceeds raised in our recent IPO, ImmixBio is sufficiently capitalized to reach what we believe will be 2 upcoming inflection points: clinical data from IMX-110 monotherapy clinical trial, as well as clinical data from the IMX-110 combined with BeiGene anti-PD-1 tislelizumab clinical trial," said Ilya Rachman, MD PhD, CEO of ImmixBio. "The current market situation allows us to capture additional value for all shareholders through this measured buyback program. Our interests have always been, and continue to be, aligned with all IMMX shareholders."

08:24 EDT Hasbro urges shareholders to vote for company nominees - Hasbro issued a letter to Hasbro shareholders in connection with the Company's 2022 annual meeting of shareholders to be held on June 8, 2022. The letter read in part, "Together with members of the Hasbro team, our new CEO, Chris Cocks, has spent the last several weeks meeting with many of you. We greatly appreciate the discussions we have had and the constructive relationships we have built with our shareholders through a strong history of engagement. The candid feedback we have received is invaluable as we support Chris in developing and executing our vision for the future of Hasbro. At our annual meeting on June 8, 2022, you face an important decision about Hasbro's future under the direction of our newly appointed CEO, Chris Cocks. Vote the WHITE proxy card today. The Hasbro Board is fully aligned with Chris. He has only been Hasbro's CEO for about 100 days, but his gameplan to unlock value for shareholders is clear: grow our world class portfolio of brands and amplify our industry-leading gaming portfolio by putting the consumer at the center of everything we do and creating direct relationships with our fans. As part of our ongoing commitment to board refreshment and to match the evolving and future needs of our business, we recently appointed two industry experts, Liz Hamren and Blake Jorgensen, to our Board. Liz and Blake each have a strong track record of driving change and value creation, and they bring valuable critical thinking in digital gaming, technology, brand development and capital allocation. They will advise and challenge Chris and the entire management team, along with the full Board, to drive our multigenerational play and entertainment strategy in games and the future of direct, interactive entertainment...Our Board has demonstrated its commitment to exploring all options for value creation. For example, while the timing of our eOne acquisition was unfortunate given the disruptive industry-wide impacts of the COVID-19 pandemic on TV and film production and theatrical distribution, as part of our continuous review of options to unlock shareholder value, the Board approved a sale of eOne's music business - which was not core to our Brand Blueprint strategy - while keeping valuable strategic assets from the acquisition intact. With the proceeds of the divestiture and our cash flow from operations, we were able to strategically invest in other core areas of the business and pay down more than $1 billion in long-term debt during 2021, while maintaining the dividend to our shareholders. We are on track to achieve our targeted $130 million of synergies from the eOne acquisition. With TV and film production returning to pre-COVID levels, the owned entertainment production capabilities we have in eOne will enable consumers to engage with our iconic brands across the Brand Blueprint. Our upcoming MAGIC: THE GATHERING Netflix series and the theatrical release of the blockbuster DUNGEONS & DRAGONS: HONOR AMONG THIEVES feature film in 2023 were greatly enhanced and accelerated by being part of eOne and are strong testaments to the acquisition's value and the power of our Brand Blueprint strategy."

08:23 EDT MiMedx urges shareholders to vote for independent director nominees - MIMEDX Group commented on Prescience Point Capital Management's "highly misleading" press release on May 6, 2022. MIMEDX urges shareholders to vote "FOR" the company's independent directors - Dr. Phyllis Gardner and James L. Bierman - on the WHITE proxy card. "The MIMEDX Board and management team are made up of highly qualified executives and industry leaders who have transformed the Company after years of turmoil. The Board's composition reflects significant input from shareholders and demonstrates a commitment to refreshment, increased diversity and subject-matter expertise, resulting in an entirely refreshed Board since June of 2019. The management team, led by Timothy R. Wright, has helped build an entirely new culture at the Company, rooted in ethics, integrity, and core values, which is methodically focused on strategic long-term execution. MIMEDX is confident in the steps we are taking to advance our strategy, and recently reported a third consecutive quarter of double-digit growth in our continuing portfolio of products... While Prescience Point attempts to distract shareholders with misleading facts and statements, their public comments betray their true motivation - Mr. Asbahi and Prescience Point explicitly stated their interest in a sale of AMNIOFIX or the entire business later this year."

08:22 EDT Desktop Metal 'supports' Biden Adminstration's AM Forward initiative - Desktop Metal announced its support and commitment for the Biden Administration's Additive Manufacturing Forward initiative aimed at strengthening U.S. supply chains by supporting the adoption of additive manufacturing, or industrial 3D printing, among small- and medium-sized manufacturers. Ric Fulop, Co-founder and CEO of Desktop Metal, said the time is right for the AM Forward initiative. "Additive manufacturing has long held the potential to de-risk supply chains and enable new innovations. With manufacturing reshoring already accelerating as a result of the historic supply chain disruption caused by the COVID-19 pandemic, the AM Forward initiative is a timely and progressive approach to modernizing our nation's outdated manufacturing infrastructure with cutting-edge technologies that will help ensure that the work stays here for the long term. At Desktop Metal, we are committed to making additive manufacturing accessible to companies of all sizes in terms of speed, cost, and material availability. One of the key benefits of 3D printing is supporting localized manufacturing that reduces reliance on global supply chains. Parts can be stored as digital files and easily sent around the world to be downloaded and printed as needed. By allowing manufacturers to quickly produce parts when and where needed, the need for global shipping, large inventories and overproduction is greatly reduced. Additive manufacturing is the modern manufacturing technology of the future, and it's the right time for American industry to support this transition to the next era of production."

08:20 EDT Twist Bioscience Astellas collaborate for antibodies to reduce TME - Twist Bioscience (TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma (ALPMY). Under the terms of the agreement, the companies will jointly conduct research activities to identify and optimize proprietary Twist antagonist antibodies, targeting an undisclosed checkpoint inhibitor pathway in the tumor microenvironment TME, as potential therapeutic development candidates. Ligands in this pathway are found in relatively high concentrations in the tumor microenvironment. Blocking the receptor's activation has the potential to markedly enhance anti-tumor immunity with other Astellas therapies including chimeric antigen receptor-based CAR technologies combined with Universal Donor Cells. Astellas will have the exclusive option to license any development candidates generated as part of the collaboration. "Our robust antibody discovery and optimization capabilities uniquely position us to develop antibodies with high affinity and specificity for historically difficult targets, such as those mediating immune suppression in the TME," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "This out-licensing agreement validates the capabilities of Twist-generated antibodies to enable the discovery and advancement of next generation therapies. As the first out-licensing agreement for Twist Biopharma, this deal will serve as an initial base that we intend to build on as we pursue increasingly larger and later stage out-licensing opportunities with additional partners and targets."

08:20 EDT Equillium announces three poster presentations at IMMUNOLOGY2022 - Equillium announced that three posters were presented over the weekend at IMMUNOLOGY2022, the annual meeting of The American Association of Immunologists. The meetings are taking place at the Oregon Convention Center in Portland, Oregon, May 6 - 10, 2022. Itolizumab is a first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6-ALCAM pathway, which plays a central role in modulating both the activity and trafficking of the pathogenic T cells driving a number of immuno-inflammatory diseases. Details of Itolizumab Data Presented Title: CD6 - a costimulatory receptor at the nexus of Teff / Treg development: Key Highlights, Summary and Conclusions from Presentation: First study to directly characterize the role of CD6 in the development and activity of T regulatory cells. T regulatory cells derived from CD6 low cells had greater co-expression of FOXP3 and HELIOS vs. T regulatory cells derived from isotype-treated CD6 high cells. T regulatory cells possessed greater suppressive function, with an increase of at least 50% greater inhibition of proliferation and cytokine release by T responder cells than T regulatory cells derived from CD6 high cells. CD6 low T regulatory cells were able to suppress T responder cell production of pro-inflammatory cytokines by 60% - 90% compared to CD6 high T regulatory cells. Data suggests that reduced levels of cell surface CD6 facilitate the development of T regulatory cells with greater stability and suppressive activity, and that modulating the levels of CD6 may increase the T regulatory to T effector cell ratio in patients with autoimmune and inflammatory diseases. Title: Modulating levels of cell surface CD6 is a novel mechanism for regulating T cell activity. Key Highlights, Summary and Conclusions from Presentation: CD6 high cells are highly pathogenic and levels of CD6 have been implicated in numerous autoimmune and inflammatory diseases including multiple sclerosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, and acute graft-versus-host disease. Itolizumab-induced CD6 cleavage from the surface of T cells occurs through a transcellular event between a CD6 positive T cell and a CD14 positive monocyte. This cleavage event is mediated by functional Fc receptor binding of itolizumab to FcgammaRI. The loss of the extracellular domains of CD6 from the surface results in T cells that are hyporesponsive and less alloreactive to T cell stimulation. These results further support targeting CD6 as an effective means to inhibit pathogenic T cell activity in the treatment of autoimmune and inflammatory diseases as CD6 cleavage results in prolonged modulation of T cell activity. Title: The CD6-ALCAM pathway selectively modulates pathogenic T cell migration. Key Highlights, Summary and Conclusions from Presentation: CD4 positive and CD8 positive T cells that migrate in response to CXCL12, express higher levels of CD6 and that the amount of migration correlates with levels of CD6 expression, suggesting that CD6 is engaged during T cell migration across the endothelial monolayer. Decreasing CD6 expression led to decreased migration of effector memory T cells and terminally differentiated effector memory T cells while migration of T regulatory cells was unaffected, thus suggesting that targeting CD6 in autoimmune and inflammatory diseases would decrease infiltration of pathogenic T cells while still permitting modulation of the immune response by T regulatory cells. Th17 cells were stained from the total peripheral blood mononuclear cells population that migrated in response to CXCL12. Data showed a reduction of the migration of those cells after blocking the CD6-ALCAM pathway with itolizumab. This data suggests that CD6-ALCAM pathway is involved in the movement of T cells through the endothelial tissues and confirms CD6 as a target to prevent pathogenic T cell recruitment into inflamed organs.

08:18 EDT Ballard Power partners with Wisdom Motor for adoption of fuel cell vehicles - Ballard Power entered a strategic collaboration with Wisdom Motor Company, Templewater Group, and Bravo Transport to accelerate the adoption of commercial fuel cell electric vehicles in Hong Kong. Templewater, an alternative asset management firm and parent company of Bravo - Hong Kong island's largest transit operator, together with Ballard, co-invested in a Series A funding for Wisdom, a technology company that designs and manufactures zero emission commercial vehicles. The Series A funds will support Wisdom's organizational growth, R&D, and manufacturing platforms, including the expansion and development of its hydrogen zero emission fuel cell truck, bus, and specialty vehicle offerings for international markets. The transaction is expected to close in Q2, subject to completion of regulatory approvals and customary closing conditions. Wisdom's hydrogen vehicle product lines will exclusively deploy Ballard's PEM fuel cell technology, with modules supplied by the Weichai-Ballard Joint Venture in China. Ballard intends to enter into a joint development agreement with Wisdom to advance the integration and optimization of its fuel cell electric powertrain designs and control strategies. Ballard is supporting Wisdom on the introduction of a new double-decker fuel cell bus, which is planned to be demonstrated in 2022 by Bravo as part of its initiative to replace its entire fleet of buses in Hong Kong with zero-emission models. As part of Ballard's equity investment, Alfred Wong, Ballard's Managing Director of Asia Pacific, will serve on the board of directors of Wisdom.

08:17 EDT Immix Biopharma announces $1M share repurchase program - Immix Biopharma announced that its board of directors has authorized a share repurchase program to acquire up to $1M of the company's common stock. As of December 31, 2021, the company had approximately $18M of cash, cash equivalents and marketable securities. The company had approximately 13.9 million shares of common stock outstanding as of April 15, 2022. "We are confident that with the $24.2 million gross proceeds raised in our recent IPO, ImmixBio is sufficiently capitalized to reach what we believe will be 2 upcoming inflection points: clinical data from IMX-110 monotherapy clinical trial, as well as clinical data from the IMX-110 combined with BeiGene anti-PD-1 tislelizumab clinical trial," said Ilya Rachman, MD PhD, CEO of ImmixBio. "The current market situation allows us to capture additional value for all shareholders through this measured buyback program. Our interests have always been, and continue to be, aligned with all IMMX shareholders."

08:16 EDT Ventyx Biosciences names William Sandborn as president and chief medical officer - Ventyx Biosciences announced the appointment of William Sandborn, MD, as President and Chief Medical Officer. Most recently, Dr. Sandborn was a co-founder and Chief Medical Officer at Shoreline Biosciences. "I am delighted to welcome Bill to the Ventyx leadership team," said Raju Mohan, CEO. "In addition to being an accomplished physician, a world-renowned immunologist and an expert in the field of inflammatory bowel disease, Bill has also played a key role in the development of a number of approved therapies in the immunology space, both small-molecules and biologics. As Chairman of our Clinical Advisory Board, Bill has already played a vital role in developing and shaping our clinical strategy and now, in his new role as both President and CMO, he will lead our clinical development team as we advance our diverse portfolio that targets multiple immune-mediated diseases."

08:15 EDT UiPath launches Automation Clouud Robots - UiPath introduced Automation Cloud Robots alongside a wealth of other powerful new capabilities as a part of the UiPath 2022.4 platform release. The new release provides enterprises with an even more comprehensive automation foundation to achieve fast and accurate outcomes. The new SaaS robots-along with added features that simplify how developers create automations, uplevel security and governance, and expand access to automation to Mac-deepen the reach of automation in the enterprise.

08:15 EDT Lightning eMotors, Perrone team on fully autonomous vehicle option for fleets - Lightning eMotors and Perrone Robotics have partnered to offer Class 3 - 7 commercial fleet customers self-driving, electric fleet vehicles that can be deployed for a wide range of dedicated uses. The partnership expands Lightning's zero-emissions EV platform offerings to include Perrone's AV-powered technology, TONY , a vehicle-independent retrofit kit designed to enable vehicles to transport people and goods in geo-fenced and dedicated driving routes. Vehicles equipped with Perrone's self-driving technology embedded into Lightning's vehicles for both cargo and passenger uses can be ordered immediately. "We were looking for partners who could deliver autonomous capabilities to our customers today, and in the future - and that's what Perrone offers," Lightning eMotors CEO Tim Reeser said. "We offer perhaps the widest range of electric commercial vehicles in North America, and now we have an autonomous vehicle solution for our products, ranging from ambulances to campus shuttles and other commercial applications."

08:13 EDT Principal Solar, Triad Pro to collaborate on EV energy storage solutions - Principal Solar announced that it has executed a definitive research and development agreement with Triad Pro Innovators. The Agreement establishes a relationship for cooperative research and development between Principal and Triad Pro for the purpose of creating new power storage solutions for the Electric Vehicle industry. "We believe Triad's eCell technology offers tremendous potential as a power storage solution for heavy electric vehicles," said K. Bryce "Rick" Toussaint, CPA, MBA, Principal's Chairman and CEO. "Principal's agreement with Triad is another example of our commitment to identifying and investing in near-term, real-world electric vehicle solutions that meet today's growing market demand."

08:12 EDT Legion comments on Guess's Paul Marciano's shareholder intimidation attempts - Legion Partners Asset Management, a significant shareholder of Guess?, commented on recent attempts by Guess Board of Directors member and Chief Creative Officer Paul Marciano and others to pressure Legion into silence regarding the need for change at Guess. Legion issued the following statement: "On May 3, 2022, we, along with our advisors, received a letter from a law firm representing Paul Marciano, demanding that Legion 'immediately cease and desist its publication of misleading and defamatory information about Guess Co-Founder Paul Marciano on abetterguess.com.' This letter specifically objected to our posting of legal complaints referencing that Paul Marciano has been the subject of numerous sexual assault allegations. The letter went on to threaten 'immediate[]...legal action against Legion and all others working in concert with it.' Reference Link

08:12 EDT Eledon Pharmaceuticals announces first patient dosed in Phase 2a trial - Eledon Pharmaceuticals reported that the first patient has been dosed in a Phase 2a study evaluating tegoprubart in patients with IgA Nephropathy. "There are over 150,000 Americans living with IgAN, and we believe tegoprubart has the potential to transform the current standard of care for people living with this disease," said David-Alexandre C. Gros, M.D., CEO of Eledon. "We are pleased to begin our clinical evaluation of tegoprubart in this area of great unmet need and look forward to sharing early results from this Phase 2a study at the end of the year." This multicenter, open-label study is enrolling up to 21 patients in each of two dose cohorts with confirmed diagnosis of IgAN and at least 0.75 g/24 hours of protein in their urine at the time of screening. The study will evaluate the safety and efficacy of tegoprubart, with the primary endpoint being change from baseline in urine protein after 24 weeks of therapy. Dosing will continue through 96 weeks, and change from baseline in eGFR slope will be assessed at 96 weeks. Preclinical evidence has demonstrated that blocking CD40L signaling can improve proteinuria, reduce autoantibodies, decrease immune cell infiltration into the kidneys, and improve survival.

08:12 EDT Aadi Bioscience announces collaborations with NGS providers - Aadi Bioscience announced partnerships with next generation sequencing providers and leaders in genomic testing and profiling, including Foundation Medicine, Tempus and others. "We expect these collaborations to expedite patient identification for the ongoing PRECISION 1 trial of nab-sirolimus in patients harboring tumors with inactivating alterations in TSC1 or TSC2 genes," the company said in a statement. Neil Desai, PhD, Founder, President and CEO of Aadi, stated, "We are very pleased to have these leading NGS partnerships in place. Recently published data project an incidence of approximately 12,000 advanced cancer patients with TSC1 or TSC2 definite impact alterations in the US. These collaborations should help physicians to identify patients who may be candidates for nab-sirolimus in our PRECISION 1 registrational trial. We expect to report preliminary data from this trial in the first half of next year."

08:11 EDT Avaya in strategic pact with Microsoft to deliver Avaya OneCloud - Avaya (AVYA), a global leader in solutions to enhance and simplify communications and collaboration, and Microsoft (MSFT) have expanded their global partnership by pairing the industry leading Avaya OneCloud portfolio with Microsoft Azure to provide organizations with more options to increase their productivity and customer engagement with unrivaled reliability, agility and scale. Building on the success of Avaya OneCloud Contact Center as a Service CCaaS delivered on Azure, Avaya is now expanding its partnership to include the Avaya OneCloud portfolio on Azure, for customers that want maximum flexibility to deploy in a hybrid, public or private cloud environment. "Our strategic partnership with Microsoft is an important milestone in our continued transformation to a cloud business model," said David Austin, Senior Vice President, Strategy and Alliances, Avaya. "The global scale of Microsoft helps ensure that our joint customers rapidly deploy Avaya OneCloud solutions in any cloud environment of their choice with speed, agility and cost competitiveness. This represents a tremendous opportunity for customers to accelerate their journey to the cloud, and a tremendous opportunity for Avaya to expand our go-to-market reach through the co-selling efforts we have identified with our trusted partner."

08:09 EDT BioLife Solutions executes co-marketing agreement with Coriell Institute - BioLife Solutions announced that it has executed a co-marketing agreement with Coriell Institute of Medical Research. Under the terms of the agreement, BioLife, under its SciSafe brand, will promote Coriell's biospecimen processing services and Coriell will promote BioLife's biologic storage services to the scientific research and biopharma markets. The parties will share revenue generated from these co-marketing activities.

08:08 EDT Imax announces $33M opening for 'Doctor Strange in the Multiverse of Madness' - Imax (IMAX) cast a powerful spell on the global box office this weekend with a $33M opening for Disney (DIS)/Marvel's "Doctor Strange in the Multiverse of Madness" - the biggest May worldwide opening ever for IMAX. The film vaulted to elite company, ranking as the fifth biggest global IMAX opening ever for a Marvel film. The strong debut was led by a slew of historic performances around the world, where "Doctor Strange in the Multiverse of Madness" delivered a top ten all-time IMAX opening weekend in 48 out of 68 international markets. That includes eight international markets where the film delivered the biggest IMAX opening weekend of all time, including India, Malaysia, Singapore, Argentina, Turkey, Vietnam, Lebanon, and Nigeria.

08:08 EDT Lincoln Educational sees low double digit start growth in Q2

08:06 EDT L.S. Starrett Co reports Q3 EPS 57c vs. 41c last year - Reports Q3 revenue $60.5M vs. $55M last year.

08:05 EDT Atlantica Sustainable Infrastructure reiterates guidance for 2022 - Atlantica is reaffirming its guidance for 2022 and continues to target Adjusted EBITDA of between $810 million and $870 million and CAFD of between $230 million and $250 million.

08:03 EDT Points International trading halted, news pending

08:00 EDT ServiceSource trading halted, news pending

07:56 EDT Terminix to divest UK, Norway businesses as condition of Rentokil merger - Terminix Global Holdings, Inc. (TMX), announced it has entered into a definitive agreement to divest its pest management businesses in the U.K and Norway. These businesses are being divested by Terminix as a condition to the closing of its pending merger with Rentokil Initial (RTOKY). The Divestment is expected to close in the next 30 to 60 days, subject to limited closing conditions. Terminix expects to record a loss on the sale of these assets in the period ending June 30, 2022. Together, the two businesses were expected to generate approximately $60M in revenue and less than $10M in Adjusted EBITDA for the full year 2022. Completion of the Divestment and the previously announced completion of the antitrust review process in the US will satisify two of the closing conditions to the Company's pending merger with Rentokil. Remaining conditions to be satisified include approval by the Company's and Rentokil's shareholders, and the registration of Rentokil's American depository shares with the U.S. Securities and Exchange Commission and their listing on the New York Stock Exchange. Both parties continue to make good progress on satisfying these remaining conditions and the transaction remains on track for completion in the second half of 2022, with a targeted closing by the end of the third quarter.

07:49 EDT Lordstown Motors reports cash, equivalents of $203.5M at March 31 - The company said, "On March 31, 2022, we had cash and cash equivalents of $203.5 million. Including the $50 million final purchase price down payment from Foxconn received on April 15th, along with $30 million remaining purchase price under the APA and $27 million estimated reimbursement of certain operating and expansion costs to be received at closing, the company's pro forma cash balance would have been over $300 million. The APA remains subject to closing conditions and may not be consummated." "Our team members are incredibly committed and continue to work tirelessly to execute on our priorities," said Adam Kroll, CFO of Lordstown. "We are managing through a tough macroeconomic environment, and we are focused on managing our liquidity as we bring the Endurance to launch. At the same time, we understand that raising additional capital is critical to our ability to achieve our business plan in 2022 and beyond."

07:47 EDT Lordstown Motors reaffirms Q3 target for start of Endurance production - The company is reaffirming third quarter 2022 target for start of commercial production of the Endurance and initial production of approximately 500 units; commercial deliveries expected in Q4. See balanced approach to allocate existing capital on the critical path items to get the Endurance to market. Production ramp plan will be aligned with bill of material cost reductions and capital raising efforts.

07:47 EDT NeoGenomics appoints Vishal Sikri as presdent, CCO of Inivata - NeoGenomics announced the appointment of Vishal Sikri as President and CCO of Inivata and the departure of former President of Inivata Dr. Clive Morris. Vishal will officially join NeoGenomics on May 23, 2022 and Dr. Morris will assist in the leadership transition over an appropriate handover period. Vishal Sikri has over 20 years of experience in the somatic diagnostics space and most recently was President of Oncology at Invitae. Separately, on Friday May 6th we issued an 8-K that the President of Pharma Services Division, Dr. Gina Wallar, is resigning from her position effective May 27, 2022 to pursue other professional opportunities. In connection with Dr. Wallar's departure, Ms. Jennifer Rose will assume interim responsibilities for the Pharma Services Division. Ms. Rose joined the Company in December 2015 and currently serves as our Vice President of Pharma Sales and Project Management Operations.

07:41 EDT Chatham reaffirms withhold vote against two Rayonier directors - Chatham Asset Management, a private investment firm which manages funds that beneficially own approximately 6.3% of the outstanding common stock of Rayonier Advanced Materials and is a substantial bondholder of the Company, issued an open letter to RYAM shareholders reaffirming its intention to withhold its vote against two long-tenured members of the Company's Board of Directors, Thomas Morgan and Lisa Palumbo, at the Company's annual meeting of shareholders on May 16, 2022. The letter read in part, "On April 13, 2022, we wrote an open letter to shareholders detailing the reasons for why we intend to withhold our votes against two long-tenured members of the Company's Board of Directors, Thomas I. Morgan and Lisa M. Palumbo, at the Company's annual meeting of shareholders on May 16, 2022. In that letter, we expressed our view that a withhold vote against Mr. Morgan and Ms. Palumbo is warranted, not only to show that this Board must be held accountable for years of shareholder value destruction, but also for their incredible entrenchment maneuver in adopting a poison pill without shareholder approval, despite having the ability to allow shareholders to vote on it at the Annual Meeting. We also expressed serious concerns with the Company's strategy in waiting to address the refinancing of the 2024 Notes in light of weakening credit markets and rising interest rates...While we recently had some engagement with management regarding our concerns, new potential terms for a refinancing and further debt reduction, we were disappointed to hear that the Company continues to believe it can wait for both market conditions and the Company's operating performance to improve. We find this risk of waiting to be a dangerous strategy further warranting our WITHHOLD votes. According to the Company's Corporate Governance Principles, if any director fails to receive the affirmative vote of a majority of the votes cast with regard to his or her election, then such director must tender his or her resignation to the Board. The Board's Nominating and Corporate Governance Committee would then consider such resignation and make a recommendation to the Board as to whether to accept or decline the resignation. The Board would then make a determination and publicly disclose its decision and rationale within 90 days after receipt of the tendered resignation. In our view, a WITHHOLD vote against Thomas I. Morgan and Lisa M. Palumbo, who have both served on the Board for eight years, is warranted to send a strong and clear message that the Board should not have defensively and unilaterally adopted a poison pill and must act with speed to address its upcoming debt maturity."

07:41 EDT uCloudlink provisionally identified by SEC as Commission-Identified Issuer - uCloudlink provided an update on its status under the Holding Foreign Companies Accountable Act: "The Company is aware that it has been provisionally identified by the United States Securities and Exchange Commission as a Commission-Identified Issuer under the HFCAA on May 4, 2022 U.S. Eastern Time. The Company understands that such identification may have resulted from its filing of the annual report on Form 20-F for the fiscal year ended December 31, 2021 with the SEC on April 27, 2022. The Company understands the SEC made such identification pursuant to the HFCAA and its implementation rules issued thereunder, and this indicates that the SEC determines that the Company used a registered public accounting firm whose working paper cannot be inspected or investigated completely by the Public Company Accounting Oversight Board of the United States to issue the audit opinion for its financial statements for the fiscal year ended December 31, 2021. In accordance with the HFCAA, if the SEC determines that the Company filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit the shares or American depositary shares of the Company from being traded on a national securities exchange or in the over-the-counter trading market in the United States. The Company has been actively exploring possible solutions. It will continue to comply with applicable laws and regulations in both China and the United States and strive to maintain its listing status on the Nasdaq Stock Market."

07:40 EDT Genenta Science appoints Obara as VP Business Development - Genenta Science announces the appointment of Tim Obara as Vice President, VP, Business Development. He joins Genenta from the University of Pennsylvania Gene Therapy Program, where he was Executive Director of Research Operations.

07:39 EDT NewLake Capital Partners enters revolving credit facility - NewLake Capital Partners announced that it has entered into a five-year revolving credit facility with a $30M initial commitment. The Credit Facility contemplates an expansion to $100M as additional lenders are added. The Credit Facility has a fixed interest rate of 5.65% for the first three years and a floating rate thereafter. "We are pleased to announce NewLake's inaugural credit facility," said Anthony Coniglio, President and Chief Investment Officer. "Access to this additional capital will allow us to continue our disciplined approach to investing in high-quality assets in the growing cannabis industry and the revolving nature of this facility will help us to efficiently manage our capital usage."

07:38 EDT Lincoln Electric appoints Dietrich as EVP, CIO - Lincoln Electric announced Lisa Dietrich has been named as Lincoln Electric's Executive Vice President, EVP, Chief Information Officer, CIO, effective immediately. In this role, Dietrich will oversee the Company's enterprise information technology systems, cybersecurity, and global IT initiatives that advance the Company's Higher Standard 2025 Strategy. She most recently served as Senior Vice President, CIO at American Greetings Corporation.

07:34 EDT Adaptimmune names Joanna Brewer as chief scientific officer - The company has appointed Dr. Joanna "Jo" Brewer as its Chief Scientific Officer effective May 4; Dr. Brewer previously served as the company's SVP Allogeneic Research.

07:34 EDT Adaptimmune sees cash, equivalents funding operations into early 2024 - The company believes that its existing cash, cash equivalents and marketable securities, together with the additional payments under the Strategic Collaboration and License Agreement with Genentech, will fund the company's current operations into early 2024.

07:30 EDT Mereo BioPharma announces top-line efficacy data from Astraeus Phase 2 trial - Mereo BioPharma Group announced top-line efficacy and safety results from "ASTRAEUS" a Phase 2 study of the investigational oral neutrophil elastase inhibitor, alvelestat, in patients with severe alpha-1 antitrypsin deficiency-associated emphysema. The double-blind placebo-controlled study evaluated two different doses of alvelestat or placebo, over a 12-week period and the effect on three primary biomarker endpoints associated with AATD-related lung disease, blood neutrophil elastase activity, Aalpha-val360 and the elastin breakdown product, desmosine. A total of 99 patients were enrolled and 98 patients were dosed in the study. At the high dose, alvelestat demonstrated statistically significant changes versus placebo in all three primary biomarker endpoints. "These positive top-line results demonstrate the clear impact of alvelestat on key known biomarkers along the pathogenic pathway of AATD-LD," said Dr. Denise Scots-Knight, Chief Executive Officer of Mereo. "Alvelestat has the potential to be the first-in-class oral neutrophil elastase inhibitor for the treatment of AATD-LD. We look forward to analyzing the additional data on the secondary and exploratory endpoints and to engaging with the regulators on the design of a pivotal study."

07:28 EDT Armstrong Flooring trading halted, news pending

07:28 EDT Asante Gold announces crusher start up at Bibiani gold mine - Asante Gold announced the successful refurbishment and operation of the primary crusher and associated equipment at the Bibiani Gold Mine. Stockpiling of crushed ore to support the imminent commencement of processing will continue for several weeks, while downstream process plant equipment is commissioned and confirmed operational. The Bibiani Gold Mine came out of care and maintenance in September 2021 and an extensive refurbishment program has continued since that time. With the support of its key contractors, Asante is on track to pour gold in the third quarter 2022, the company said in a statement.

07:24 EDT Akari Therapeutics presents results from two preclinical development programs - Akari Therapeutics presented "positive" results from two preclinical studies of its lead asset, investigational nomacopan, in diseases of the eye at the Association of Research in Vision and Ophthalmology 2022 Annual Meeting. Preclinical data show investigational intravitreal long-acting PASylated-nomacopan effective in inhibiting choroidal neovascularization, which is a risk related to certain complement inhibitors that otherwise appear to be effective in the treatment of GA1, 2. Initial pharmacokinetic and pharmacodynamic data from a standard model confirm bioavailability of PAS-nomacopan in the retina and suggest that a clinical dose interval of three months or more may be possible; frequent intravitreal injections are a significant burden on patients in the treatment of retinal diseases In a separate preclinical study, investigational nomacopan downregulated cells implicated in surface-of-the eye inflammation in EIC compared to dexamethasone and cyclosporin.

07:23 EDT 908 Devices announces updates to MX908 handheld mass spec device - 908 Devices announced updates to its MX908 handheld mass spec device, adding new capabilities to streamline workflows and improve field safety for first responders. The device will now include enhanced Bluetooth features with remote applications for iPhone mobile devices, as well as a broader range of drugs, including fentanyl analogs and synthetic opioids and cannabinoids.

07:22 EDT AN2 Therapeutics appoints Maggie FitzPatrick to board of directors - AN2 Therapeutics announced the appointment of Maggie FitzPatrick to its Board of Directors. Maggie FitzPatrick is a highly accomplished corporate affairs executive who has led global communications and public affairs at leading healthcare companies, including Johnson & Johnson and Cigna.

07:18 EDT Farmland Partners says 'Short and Distort' class action suit concluded - Farmland Partners announced that the deadline to appeal has passed with no appeal filed by the plaintiff from the U.S. District Court's April 6 ruling dismissing the class action lawsuit against the Company and certain of its executives. The class action suit has been pending since July 2018, when FPI, its management, and its shareholders were targeted by short sellers who knowingly printed false information about the Company to manipulate its stock price and profit from the resulting price drop. The author of those attacks has since admitted the falsity of numerous allegations, which were at the core of the class action case. The Company expects the plaintiff's decision to forego an appeal of the district court's order will result in the dismissal of two shareholder derivative lawsuits associated with the underlying class action lawsuit, according to statements from the plaintiffs' attorneys in recent court filings in those cases. FPI will continue to pursue its claims against the hedge fund that was involved in the short-and-distort attack. "This class action litigation has hung over our Company for a long time, forcing us to spend considerable resources to defend ourselves from baseless accusations," said FPI Chairman and CEO Paul Pittman. "Today, we can finally close this chapter and move on to doing what we do best - investing in high-quality farmland across the country and delivering for our shareholders."

07:17 EDT Macellum urges Kohl's shareholders to vote for director nominees - Macellum Advisors GP, a long-term holder of nearly 5% of the outstanding common shares of Kohl's Corporation issued a letter to fellow shareholders. The letter read, in part, " Over the past two years, Macellum has worked tirelessly to help improve the Board and unlock enhanced value for all of the Company's stakeholders following more than two decades of stagnation. In 2021, we were able to add two highly qualified director designees, Thomas Kingsbury and Margaret Jenkins, to what became a 13-person Board. We were also able to facilitate the departure of a Chairman with a 30-year tenure and drive the Company to increase share repurchases. Unfortunately, these incremental changes were not enough to help Kohl's deliver better results and keep pace with other soft goods retailers that began to grow in the post-pandemic environment. As evidence, the Company's share price dropped 22% from the point in which we settled to the point in which we initiated a new campaign this year , while several peers generated far better performance With the Annual Meeting in just two days, we urge our fellow shareholders to reflect on the following before casting their final ballots: We believe voting on Macellum's WHITE proxy card for at least a subset of our nominees, including a shareholder representative, is the best insurance policy for shareholders, regardless of whether a sale occurs or not. If Kohl's is on its way to being sold for a fair price, that will be a great outcome for shareholders. Voting for Macellum's nominees will not change that outcome of a sale. In fact, our nominees would likely serve at a handful of meetings to discuss and approve a transaction and then would be another set of eyes in the boardroom for shareholders to help ensure a transaction is successfully completed. However, should the Board have a sudden change of heart due to the reelection of incumbents and misconstrues those results as support for management's standalone plan, you should want Macellum nominees in the boardroom. We fear, as does Morgan Stanley analysts, that the Company's share price could tumble into the low to mid $40s, effectively destroying more than $1.5 billion in value, if a sale is not achieved. The Company's standalone plan was not only poorly received when released on March 7, 2022, as reflected with a 13% drop in the stock price on that same day, but also relies on something that has not occurred in 10 years at Kohl's - sales growth. It is especially concerning that the current Board appears to be using, based on management's standalone plan, targets of $75 per share to $88 per share to benchmark offers against. We struggle to see any scenario where the Company's capital-intensive and risky plan, which projects declining EBIT and increasing capital expenditures, will result in anything close to recently reported offers, even 3-years from now. Shareholders should be wary of the Company's refusal to share its results for the first quarter of fiscal 2023, despite their claims of business momentum. Underperformance in the first quarter of 2023, after a weak fourth quarter in fiscal 2022, would be more validation of a strategy that is not working. Shareholders need to ask why they are being forced to vote at the Annual Meeting without this critical piece of information...We strongly urge you to help protect all shareholders and stakeholders by voting on Macellum's WHITE proxy card. In our view, the greatest risk we can take as shareholders is doubling down on the current Board and management team once again after the last 20+ years of stagnation at Kohl's."

07:16 EDT Blackstone expands presence in Canada with new office led by Janice Lin - Blackstone announced that it is establishing a Blackstone Real Estate office in Toronto and the appointment of Janice Lin as head of its Real Estate business in Canada. Ms. Lin's leadership experience and deep knowledge of the Canadian market will help drive Blackstone Real Estate's Canadian footprint as it continues to invest across all asset classes, with a focus on its long-term presence in the country. Blackstone has long had a significant presence in Canada across its businesses, including CAD $14 billion of real estate assets totaling approximately 450 properties - consisting primarily of logistics. Blackstone's portfolio companies across the firm employ more than 3,550 people in Canada. Nadeem Meghji, Blackstone's Head of Real Estate Americas, said, "We are excited to officially open a real estate office in Canada and welcome Janice to lead our real estate business in the country. We are long-term believers in the strength of the Canadian economy, and we look forward to leveraging her expertise and on-the-ground views to help us expand our presence in the Canadian real estate market." Ms. Lin added, "Blackstone's long-term investment approach has enabled it to build a growing logistics, office, and residential footprint across Toronto, Montreal, and Vancouver. Canada's population growth is the highest among G7 nations and is nearly double that of the U.S., and I believe that will continue to create exciting opportunities in the market. I look forward to strengthening Blackstone's strong presence in Canada and supporting businesses across a number of different sectors."

07:13 EDT WideOpenWest doubles Greenfield expansion plans to 400,000 homes passed by 2027 - WideOpenWest will double its Greenfield expansion plans to 400,000 homes passed by 2027, a 21% increase in the company's total homes passed, and will increase its Greenfield investment to a total of $400M. The increase reflects the plan to add nearly 30,000 homes passed in Greenville County, South Carolina, newly identified opportunities for growth in Central Florida, and future markets. WOW! plans to invest more than $30M in Greenville County and reach more than 28,000 homes passed in the communities of Five Forks, Fountain Inn, Mauldin, Piedmont and Simpsonville. Combined with recently announced expansion plans in Seminole County and Orange County, Florida, WOW! expects to reach nearly 180,000 new homes passed, exceeding the company's earlier projection of 100,000.

07:13 EDT Lensar expects cash to fund operations into 2023 - As of March 31, 2022, the Company had cash and cash equivalents of $29.0 million as compared to $31.6 million at December 31, 2021. Cash utilized in the quarter was $2.6 million and compares to $4.7 million used in the first quarter of 2021. Based on its cash position and operational forecasts, the Company believes it has sufficient cash to fund operations through the expected launch of ALLY and into 2023.

07:08 EDT ADC Therapeutics CEO Chris Martin steps down, Ameet Mallik to succeed - ADC Therapeutics announced that Chris Martin, DPhil, has stepped down as CEO. Dr. Martin will serve as a non-executive member of the Company's Board of Directors and Chair of the Science and Technology Committee. He will also serve as an advisor to the Company for the next three months to ensure a seamless transition. ADC Therapeutics is pleased to announce that Ameet Mallik has been appointed as its new CEO. He will be based from ADC Therapeutics' office in New Providence, New Jersey. Ameet Mallik's pharmaceutical career was highlighted by 16 years at Novartis, most recently as Executive Vice President and Head of U.S. Oncology.

07:05 EDT Canadian Solar secures 100 MWH EPC contract in UK - Canadian Solar announced it has entered the utility scale energy storage market in the United Kingdom after signing the agreements to provide integrated energy storage systems, and Engineering, Procurement and Construction services for four battery storage projects. Pulse Clean Energy is the owner of the four projects of more than 100 MWh. The agreements mark the start of a long-term partnership between the companies. In addition to providing the battery storage systems and construction services, Canadian Solar will maintain and operate the projects via a 10-year long-term service agreement. Canadian Solar's solutions will enable Pulse Clean Energy to optimize ancillary grid-services, enhance energy balancing capabilities, and capture multiple streams of revenue.

07:01 EDT R1 RCM to provide revenue cycle management services for ScionHealth hospitals - R1 RCM and ScionHealth have entered into a 10-year agreement that will make R1 the exclusive provider of revenue cycle management - RCM - services for ScionHealth's 61 long-term acute care hospitals - LTACHs -. Launched in December 2021, ScionHealth is a new health system comprised of 61 LTACHs previously owned by Kindred Healthcare and 18 short-term acute care community hospitals previously owned by LifePoint Health.

06:52 EDT Myovant Sciences and Accord Healthcare to commercialize Orgovyx in Europe - Myovant Sciences and Accord Healthcare have entered into an exclusive license agreement for Accord to commercialize relugolix for the treatment of advanced hormone-sensitive prostate cancer under the trade name Orgovyx in the European Economic Area, U.K., Switzerland and Turkey, with the right of first negotiation if Myovant decides to enter into licensing arrangements in countries in the Middle East, Africa and India. Myovant will receive an upfront payment of $50M and is eligible to receive commercial launch, sales-based and other milestones totaling up to $90.5M. In addition, Myovant is eligible to receive tiered royalties from the high-teens to mid-twenties on net sales. Myovant will continue to lead the global development of relugolix and provide initial product supply to Accord. Accord will be responsible for certain local clinical development, all commercialization for its territories, and has the option to manufacture relugolix in the future. On April 29, the European Commission approved the marketing authorization application for Orgovyx for the treatment of adult patients with advanced hormone-sensitive prostate cancer. The decision applies to all 27 European Union member states plus Iceland, Norway, and Liechtenstein. The marketing authorization application for Orgovyx is pending review by the U.K. Medicines and Healthcare Products Regulatory Agency. Accord expects to launch Orgovyx in Europe in the second half of calendar year 2022.

06:46 EDT Lion Electric reports 10M miles driven - Lion Electric Company kicked off the Advanced Clean Transportation Expo in Long Beach, Calif., by announcing that the company has reached a major operational milestone, with its vehicles on the road collectively surpassing 10 million miles driven to date.

06:44 EDT Biolase appoints Kenneth Yale to board of directors - BIOLASE announced that Kenneth Yale, D.D.S., J.D. was newly elected to its Board of Directors, effective April 28, 2022. Yale is currently on the Board of Visitors at the University of Maryland School of Dentistry, and a consultant to the United States Department of Defense, a position he has held since March 2020.

06:43 EDT Noble Corp., Maersk Drilling provide update on merger control process - Noble Corporation and The Drilling Company of 1972 provided an update on the ongoing merger control process for the business combination announced on 10 November 2021. On 22 April 2022, the UK Competition and Markets Authority announced its Phase 1 decision, pursuant to which it concluded that the Transaction gives rise to a realistic prospect of a substantial lessening of competition in relation to the supply of jack-up rigs in North West Europe and that a remedy to address such effect would be required to avoid a reference to a Phase 2 review. On 29 April 2022, the Parties submitted remedy proposals to the UK CMA to address such effect identified in the UK CMA's decision of 22 April 2022. Each of the Remedy Proposals was designed to replicate the competitive constraint provided by Noble in respect of jack-up rigs in NW Europe by the divestment of certain jack-up rigs to a suitable purchaser. On 9 May 2022, the UK CMA published its decision that there are reasonable grounds for believing that one of these Remedy Proposals might be accepted by the UK CMA. This one Remedy Proposal comprises the divestment of the rigs Noble Hans Deul, Noble Sam Hartley, Noble Sam Turner, Noble Houston Colbert, and Noble Lloyd Noble including all of the related support and infrastructure that the purchaser will need to run the Remedy Rigs as an effective standalone business. Relevant off-shore and on-shore staff are expected to transfer with the Remedy Rigs. On this basis, the Parties will seek to reach an agreement with a potential purchaser regarding the sale of the Remedy Rigs under the Remedy Proposal. The UK CMA will need to consider the purchaser a suitable purchaser. Following its decision that it might accept this Remedy Proposal, the UK CMA will review the terms of the Remedy Proposal and the suitability of potential purchasers. This will include seeking third party comment. The duration and outcome of the UK CMA review process remains uncertain. If a Remedy Proposal is accepted by the UK CMA, closing of the Transaction is expected to occur in mid-2022. The Parties believe that the financial and strategic rationale underpinning the Transaction remains intact and compelling for all stakeholders irrespective of the divestment of the Remedy Rigs. The Parties' estimated annual run-rate cost synergies goal also remains unchanged. Further, the Parties do not intend to change the exchange ratio agreed between them for purposes of the Transaction.

06:40 EDT Icahn Enterprises announces extension, amendment of Southwest Gas tender offer - IEP Utility Holdings LLC, an affiliate of Icahn Enterprises L.P., announced that it has extended the expiration date of its tender offer to purchase shares of the common stock, par value $1.00 per share, of Southwest Gas Holdings, Inc., a Delaware corporation, including the associated rights issued pursuant to the Rights Agreement, dated October 10, 2021, between the Company and Equiniti Trust Company, as rights agent, that are issued and outstanding, for $82.50 per Share in cash, without interest, less any applicable withholding taxes, until 12:00 midnight, New York City time, on Friday, May 20, 2022, unless further extended or earlier terminated in the event that a condition to the Offer becomes incapable of being satisfied. As previously announced, on May 6, 2022, the Offeror and its affiliates entered into a cooperation agreement with Southwest Gas regarding the proxy solicitation conducted by affiliates of the Offeror and the Offer. Among other things, the cooperation agreement provides that Southwest Gas will amend the Rights Agreement so that the Offeror may acquire up to 24.9% of the Shares. As a result of the amendment to the Rights Agreement, the poison pill will not be triggered upon the closing of the Offer. Pursuant to the terms of the cooperation agreement, the Offeror announced today that it is amending the Offer to reflect that the Offeror is now seeking to purchasean aggregate number of Shares such that the Offeror and its affiliates will own up to 24.9% of the issued and outstanding Shares upon closing of the Offer, at a price of $82.50 per Share, net to the tendering stockholder in cash, without interest, less any applicable withholding taxes, in the Offer. In the event that the Shares tendered into the Offer exceed this amount, the Shares will be subject to "odd lot" and proration priority provisions. The Offeror also announced that it is irrevocably waiving all conditions to the Offer that have not otherwise been satisfied, so that there are no conditions to the Offer that have not been satisfied or waived. A Supplement to the Offer to Purchase and certain other related documents are being mailed to the stockholders of Southwest Gas.

06:23 EDT High Tide appoints Greg Fleury as CTO - High Tide announced that Greg Fleury has joined the company in the role of Chief Technology Officer. In his most recent prior role as Vice-President of Digital and Technology for Edo Japan, he led the development of that company's ordering app, website, data warehouse, and analytics systems. As Chief Technology Officer, Mr. Fleury will be responsible for leading High Tide's global technology and digital operations, overseeing the development of digital platforms, digital commerce, security, and analytics. He will also be responsible for managing High Tide's IT infrastructure.

06:20 EDT Valour, SEBA Bank, MVIS launch SEBA VALOUR Metaverse Index - DeFi Technologies announced that Valour has partnered with SEBA Bank and MarketVector Indices to launch the SEBA VALOUR Metaverse Index. The SVMETA index is an investable index for tokens building for the Metaverse that provides exposure to crypto assets related to gaming, entertainment and social interactions within the virtual and augmented reality world. SVMETA is a rules-based index that covers the CCCAGG pricing and is calculated in USD as a price index. The index is reviewed on a monthly basis.

06:17 EDT i-80 Gold to acquire strategic land sections from Nevada Gold Mines - i-80 GOLD CORP. (IAUCF) announced that it has entered into an agreement to acquire strategic land sections adjoining the Company's Granite Creek Property located in Humboldt County, Nevada from Nevada Gold Mines (GOLD, NEM). The new property includes unpatented claims in Section 6, T. 37 N., R. 42 E. and surface and mineral rights for Section 21, T. 38 N., R. 42 E. The new property sections provide i-80 with approximately 3.2 kilometres of additional exposure along the Getchell/Range Front fault structure that is intimately associated with the Granite Creek and Turquoise Ridge gold deposits. Importantly, the property section to the north of Granite Creek is immediately on-strike with the recently discovered South Pacific Zone where high-grade mineralization is being defined along strike to the north of the Company's Granite Creek Mine. Highlights of this property purchase include: Increases the size of i-80's Granite Creek Property package by approximately 1,280 acres; Extends exposure approximately 1.6 km north towards NGM's Turquoise Ridge Mine, and 1.6 km south of Granite Creek along the favourable Getchell/Range Front fault structure; Provides a 100% interest in the potential northern extension of the South Pacific Zone where recent drilling has identified significant high-grade mineralization including: 16.3 g/t Au over 7.1 m in hole iGS21-03; 14.7 g/t Au over 10.2 m in hole iGS21-04; 17.2 g/t Au over 3.8 m and 22.0 g/t Au over 3.4 m in hole iGS21-07;25.5 g/t Au over 5.5 m in hole iGS21-11; 11.0 g/t Au over 9.1 m in hole iGS21-12; 16.3 g/t Au over 15.7 m in hole iGS21-18; 15.3 g/t Au over 10.5 m in hole iGS21-19. The properties include surface and mining rights. Total consideration for the purchase of the property sections consists of a cash payment of $4 million and the inclusion of the acquired sections into the existing 10% Net Profits Royalty that NGM currently holds on the existing Property. Barrick Gold Corporation will also retain a 0.5% NSR on the new property sections. i-80 is currently completing a surface and underground drill program with multiple drills at Granite Creek that is expected to consist of approximately 30,000 metres of drilling. The program has been very successful in confirming the significant upside opportunity at Granite Creek both proximal to the underground mine workings including the expansion of mineralization along strike and at depth where the deposit remains open. The South Pacific Zone is one of the primary targets of the 2022 program and future drilling will continue to step-out to the north towards the newly acquired property. "Granite Creek is the first of four properties that i-80 is advancing towards production over the next several years, and where mining has recently commenced", stated Matt Gollat, Executive Vice-President of i-80 Gold. "Given the substantial success of our ongoing drill program in expanding mineralization, increasing our property holdings is extremely important in providing significant exposure to potential upside both to the north and south of our current property."

06:13 EDT Go Direct Global extends operations, launches Go Direct America - With the opening of fulfillment center in Columbus Ohio, Go Direct extends its footprint across North America, delivering 3PL solutions focused on B2B logistics, Direct-to-Consumer eCommerce fulfillment, custom kitting and packaging, warehousing & inventory management. The 240,000 sq ft. facility is temperature-and-humidity controlled, with the capacity to house over 15,000+ pallets. Go Direct America is committed to the exact traceability and security system that GD's clients have come to expect, including future certification on the QMS for the ISO 9001/13485/22000 and GMP compliance. Go Direct America expects to create up to 140 full and part-time positions at the location, and the operational team will be led by industry veteran Allan Hinkle, formerly of Amerisource Bergen and DHL Supply Chain.

06:11 EDT Seagen CEO Clay Siegall takes leave of absence, Roger Dansey named interim CEO - The Board of Directors of Seagen announced that President, CEO and Chairman Clay Siegall, Ph.D. is on a leave of absence. The company is aware of an alleged incident of domestic violence that occurred recently at Dr. Siegall's home. Dr. Siegall has denied these allegations and has informed the company that he is engaged in a divorce. The Board of Directors has formed a committee of independent directors and is conducting a thorough investigation with the assistance of an independent law firm. Roger Dansey, M.D., Seagen's Chief Medical Officer since 2018, has been appointed Interim CEO.

06:04 EDT BioNTech backs FY22 CapEx view EUR 450M- EUR 550M

05:56 EDT Jiayin Group says Chunlin Fan rejoins company as CFO - Jiayin Group announced Chunlin Fan has rejoined the company as CFO, effective from May 5. Bei Bai and Jin Chen, who have served as the Co-CFOs of the company since January 8, 2021, will step down from such roles and continue serving the company as Senior Financial Controller and Senior Investment and Finance Director, respectively, effective from May 5. Fan previously served as the company's CFO from January 2016 to January 2021. Prior to rejoining the company, Fan worked as the CFO of LinkDoc Techology Limited from January 2021 to March 2022.

05:53 EDT Paysafe, Playtech form global payments partnership - Paysafe announces a new global partnership with Playtech, a gambling technology company. The new agreement represents the extension of an existing partnership between the two companies into the UK and Europe from the US, where Playtech offers Paysafe's leading payment solutions to iGaming operator customers through its technology platform. Through a single, global streamlined integration with Paysafe's API, operators in the UK and Europe will now also be able to leverage Playtech's iGaming PAM, Information Management Solution platform to access a range of Paysafe's payment solutions, starting with payment acquiring and card processing, with Paysafe's digital wallet services set to follow. The integration helps to maximise consumer choice by providing players with all the ways they want to pay when betting online. The partnership extension follows Paysafe and Playtech's successful US integration with betPARX. Paysafe has powered the gaming operator's traditional and alternative payment solutions for its iGaming brand Play Gun Lake in Michigan since Q2 2021 and, from Q1 2022, for its betPARX iGaming and sportsbook app for both Pennsylvania and New Jersey.

05:50 EDT SPI Energy's Solarjuice signs 2GW supply contract with Sungrow - SPI Energy announced its SolarJuice Co. subsidiary signed a 2GW supply agreement with Sungrow, an inverter solutions supplier for renewables. The 2GW capacity of the supply contract, which includes PV inverters, storage systems, batteries, and other accessories, makes this the largest and most comprehensive contract of its kind in the Australian solar market. The parties announced the agreement at the Smart Energy Conference & Exhibition, Australia's premier event for solar, storage, and energy management, on May 6.

05:45 EDT Verona Pharma to present successful TQT analysis of ensifentrine - Verona Pharma announces the presentation of an abstract demonstrating ensifentrine met all safety objectives in a through QT study at the American Thoracic Society International Conference 2022 taking place on May 13-18. The abstract is published on the ATS website and in the peer reviewed publication, American Journal of Respiratory and Critical Care Medicine. The study results, first reported in December 2021, demonstrated no clinically relevant effects in measures of cardiac conduction including QTcF, PR and QRS intervals were observed with either 3 mg or 9 mg inhaled ensifentrine dose at any time point over 24 hours.